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Characterising the dental pulp perivascular cells will allow understanding whether 
these blood vessel associated cells have tissue regenerative potential that can be 
used for craniofacial regeneration, including bone, nerve, and tooth repair.  
Perivascular cells (pericytes and adventitial cells) can be purified from multiple human 
organs including placenta, bone marrow, pancreas, fat and muscle, and exhibit in 
culture and in vivo multilineage mesodermal developmental potential, implying the 
perivascular origin of the elusive, culture-derived mesenchymal stem cells (MSCs). 
Perivascular cells are ubiquitous in the organism and their developmental potential is 
partially imprinted by their tissue of origin. Pericytes in the dental pulp, which are 
deriving from primary or permanent teeth, originate from migrating cranial neural crest 
cells, which, theoretically, could exhibit superior potential to regenerate neural tissue. 
To test this, my aim was to characterise dental pulp cells and to evaluate their 
regenerative capacity. 
 
Material and methods  
To achieve this goal, we identified and isolated perivascular cells present in the human 
dental pulp. Dental pulp tissue was isolated from healthy third molar teeth from adults 
younger than 30 years old. Firstly, immunohistochemistry was performed to determine 








using markers such as αSMA, PDGFRβ, LepR, CD107a, CD146, NG2 and CD34. 
Blood vessels were next characterised using MSC markers such as CD44, CD90, and 
CD29 and endothelial cell markers CD54, CD34, UEA-1, and vWF on pulp sections 
by immunofluorescence microscopy. Secondly, purification of dental pulp perivascular 
cells was performed using flow cytometry, followed by culturing and differentiation 
assays towards osteogenic, adipogenic and neurogenic cell lineages.   
 
Results  
We found that the phenotype of pericytes in the dental pulp in vivo is similar to that of 
pericytes in other human organs previously documented. They express CD146, ALP 
and PDGFRβ and lack endothelial cell markers such as CD34, vWF, CD54 or UEA-1. 
Importantly, we also found that pericytes are heterogeneous and can be further 
discriminated based on NG2, αSMA and LepR that coincide with a particular blood 
vessel type or blood vessel diameter.  For example, αSMA is mainly expressed in 
microvascular pericytes and occasionally in capillaries, similar to LepR. NG2 is not 
expressed in venules but it is expressed in capillaries and arterioles. In contrast, MSC 
markers CD90, CD44, and CD29 were expressed on all pericytes suggesting that 
MSCs reside in heterogeneous perivascular niches.  
Dental pulp mesenchymal stromal cells were next derived from CD146+CD34-CD56-
CD45- pericytes or NG2+ and NG2- pericyte subsets and from CD146-CD34+CD56-
CD45- adventitial cells, another perivascular cell source of MSCs located around large 
vessels. Our data show that, similar to MSCs, all perivascular cell subsets we purified 








calcium deposits upon osteogenic induction, reminiscent of bone development. 
However, most of cell lines tested were not adipogenic with the exception of rare cells 
in the NG2+ pericytes subset. Indeed, lipid droplets were consistently found 
accumulating only in these purified pericytes from 14 days onwards, albeit at a low 
frequency.  
Finally, we discovered that, in situ, neural cells, positive for CD56 and vimentin, share 
markers with pericytes such as NG2 and CD146. We also found that in vitro, our 
perivascular cell-derived mesenchymal stromal cell lines express tubulin β III upon 
neuronal induction although these results require further confirmation.  
 
Conclusions 
We documented the molecular signature of pericytes in the human dental pulp. We 
demonstrated that perivascular cell subsets can be prospectively purified to 
homogeneity and that perivascular cell-derived stromal cell cultures can be 
established in vitro. Intriguingly, our in vitro MSC functional assays showed that these 
cells are not multipotent, and thus are not genuine MSCs. They are, in contrast, very 
potent bone progenitors with a low frequency of arterial pericytes being adipogenic. 
Importantly, we here showed a marker overlap between neural cells and pericytes. 













Figure 1. Graphical abstract.   
Human dental pulp perivascular mesenchymal cell (DPpvMSCs) types following sorting demonstrated   

















Replacement of lost bone or teeth continues to be a challenge for dental surgeons. 
Treatment modalities currently available include removable prostheses, fixed crown 
and bridgework, and inserted titanium implants. An alternative possibility to regenerate 
lost dental tissue could result in a significant improvement in quality of life for many 
patients.  
Some stem cells called “mesenchymal stem cells” are found along blood vessels and 
can be cultured and multiplied for the treatment of numerous diseases. When these 
cells are surrounding large vessels, they are called adventitial cells, and when they 
are around small blood vessels, they are called pericytes.  
The perivascular stem cells (PSCs) can be isolated from all vascularized tissues, 
including the dental pulp, and exhibit dramatic regenerative potential in bone, skeletal 
muscle, and other tissues. Although PSCs are ubiquitous in the organism, their 
developmental potential is partially imprinted by their tissue of origin.  
My project was to characterise and purify human dental pulp perivascular cells and 
assess their ability to form nerve, bone or fat tissue in vitro. To this aim, we have first 
identified the different cell types on frozen thin sections of the dental pulp, by 
microscopic detection of molecules – or “markers” – that are unique to each of these 
cell types. Next, we have purified these cells by flow cytometry, a technology whereby 
cells are sorted according to the marker(s) they express, which have been tagged with 
a fluorescent compound detected by a laser beam. Finally, purified candidate stem 








development and maturation into bone cells, fat cells, or neural cells, which are 
recognizable in the culture dish by their morphology and expression of new molecular 
markers. Our results show that the human dental pulp contains perivascular cells – 
pericytes and adventicytes – that can give rise to bone and cells that resemble those 
found in the neural system although the latter needs further confirmation. Furthermore, 
we observed that only a subset of pericytes, called NG2+ pericytes, had the ability to 
yield fat cells in culture although only a few were observed. All together, these early 
results pave the way to the identification of easily accessible stem cells that might be 
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Dental tissue  
 
Anatomy of human teeth 
Humans are diphyodonts, with an initial primary or deciduous dentition, followed by a 
secondary or permanent dentition. With very few exceptions, the deciduous teeth erupt 
into the mouth after birth. These exceptions include natal and neonatal teeth with 
incidence of 1 in 2000-3000 births and frequently occur in children born with a cleft lip 
and palate. (Haith and Benson, 2008). After the age of approximately three years, all 
the primary teeth are usually present. The permanent teeth start to appear at the age 
of around six years. The first permanent tooth that erupts is the lower first molar which 
has no deciduous predecessor. At around the same period of time, the anterior 
deciduous teeth begin to exfoliate, and these are replaced by their permanent 
successors. This process is normally complete by the age of 18 years. Considering 
that the average life is around 75 years, the functional lifespan of the primary teeth 
contributes only to 5% of it (Figure 2). 
 








Both primary and permanent teeth have three forms: incisiform, canineform and 
molariform. Incisiform teeth consist of the central and lateral incisors; they have thin 
crowns like blades for cutting. Canineform teeth are made up of the canines; they are 
used for tearing or piercing and have a pointed crown like a cone. Finally, the 
molarfiform teeth include the molars and premolars; these are used for grinding food 
and have a number of cusps. Premolars or bicuspid teeth are only present in the 
permanent dentition. 
A human tooth consists of two main parts, namely the crown and the root. The crown 
is the portion of the tooth visible in the oral cavity and has an outer layer of enamel.  
The root part is covered by cementum and is usually attached to the alveolar bone of 
the jaws by a network of periodontal ligaments (Figure 3). 
 
The enamel is the hardest and most mineralized substance in the human body It 
covers the outer layer of the teeth and it is partially responsible for tooth colour. The 
enamel consists mostly of minerals; primarily hydroxyapatite and its colour may vary 
from light yellow to a grey looking white, as it is semi translucent. Enamel forms a very 
strong barrier that protects the inner, more sensitive layers of the tooth from any 
pathology such as decay. Enamel has a very important role in protecting teeth from 
decay. Enamel unlike other tissues of the human body, such as bone, does not contain 
any living cells, so it cannot regenerate. On the other hand, the recent research from 
Elsharkawy and colleagues was very promising for enamel regeneration with the use 
of elastin-like recombinants (ELRs) (Elsharkawy et al., 2018). Dentine has less 
minerals and it is a living tissue since it contains the od processes. The odontoblasts 








early phase of the craniofacial development. The dental pulp is a soft, fibrous 
connective tissue and lies within the central cavity of the tooth enclosed by the dentine 
(Figure 3). Blood vessels are responsible for the he dental pulp vitality and neuros for 
the transmission of sensory signals. Odontoblasts are located in the outermost layer 
of the dental pulp. Through this, it creates the pulp-dentine border as a layer of 
columnar shaped polarised cells able to deposit dentine matrix under pathological and 
physiological conditions (Goldberg and Smith, 2004). At the root surface, the 
cementum covers the dentine and the periodontal ligament (PDL) is responsible for 
connecting and supporting the tooth with the alveolar bone (Figure 3). The dental and 
surrounding tissues which house the tooth within the alveolar bone are termed 
collectively as the periodontium (Nanci and Bosshardt, 2006). 
     
Figure 3. Tooth anatomy; The dental pulp tissue is located in the centre of the tooth. 
The odontoblasts are cells based in the pulp and produce dentine, which surrounds and protect the 
dental pulp. Enamel covers the dentine at the crown level. At the root part, the cementum covers the 
dentine of the tooth and also allows the periodontal ligament (PDL) to attach to the alveolar bone in 
order to stabilize the tooth. Image adopted from Cate 1998.  (Cate, 1998). 
 









Tooth development is a biological process that occurs in the developing embryo and 
it involves complex signaling between ectodermal and neural crest derived 
mesenchymal tissue (Tucker and Sharpe, 2004). At the sixth week of embryogenesis, 
after migration of the neural crest cells into the head and neck mesenchyme, ectoderm 
covering the stomodeum begins to proliferate giving rise to the dental lamina.  From 
the dental lamina, following ecto-mesenchymal interactions, ovoidal structures start to 
separate and develop into tooth germ (Figure 4). The neural crest cells differentiate 
into the dental organ, called dental papilla, and dental follicle, forming the main part of 
the dental and periodontal structures (d’Aquino et al., 2008). Therefore, dental pulp is 
made of mesodermal components, containing neural crest cells that display plasticity 
and multipotential capability (Kerkis et al., 2006). Once the mineralisation is complete, 
the pulp resides in an environment that is protected from potential differentiation 
stimuli. The dental pulp ,in human ,is thus formed by four layers which are, from the 
outer to the inner part a) the odontoblasts, which are producing dentine, b) the cell-
free zone, rich in extracellular matrix components, c) the cell-rich zone containing 
progenitor cells, and, d) the inner layer, which comprises the vascular area and 
nervous plexus (Graziano et al., 2008). Yamazaki and team reported the presence of 











Figure 4. Tooth development stages: histological. 
Crown formation is the initial stage followed by root development after the completion of the first one. 
At the bell stage, the epithelium derived ameloblasts and odontoblasts originating from the 
mesenchyme deposit of the enamel and dentine respectively. The root is covered initially by dentine 
and cementum which are quite soft as ameloblasts and enamel are missing. Ep: epithelium, mes: 
mesenchyme, sr: stellate reticuculum, dm: dental mesenchyme, dp: dental papilla, df: dental follicle, ek: 

















Mesenchymal stem cells  
 
Definition and discovery of mesenchymal stem cells 
 
The presence of cells with osteogenic potential in the bone marrow was  described by 
Tavassoli using entire fragments of bone-free bone marrow (Tavassoli and Crosby, 
1968).  However, Alexander Friedenstein was the first one to describe these cells in a 
more detailed manner when he found that a population of adherent cells from human 
bone marrow gives rise to clones, and could give rise to fibroblasts in culture 
(Friedenstein, 1976; Friedenstein et al., 1974, 1966).  The observation he made was 
that these cells are not affiliated to the hematopoietic cell lineage and have the ability 
to give rise to bone and cartilage-forming cells.  
 
Further characterisation of these cells performed by Owen and Friedenstein (Owen 
and Friedenstein, 1988) and Piersma and team (Piersma et al., 1985) and in addition 
to further investigations (Friedenstein et al., 1987; Wakitani et al., 2002) demonstrated 
that these cells, isolated by plastic adherence, can form osteoblasts, chondrocytes, 
adipocytes and myoblasts. Accordingly, multipotent progenitors cultured from total 
mouse bone marrow were shown to exhibit developmental plasticity, giving rise to 
diverse mesodermal cell lineages. The term “mesenchymal stem cells” or MSCs was 
first used by Arnold Caplan (Caplan, 1991). Caplan drew a parallel with the stem cells 
at the origin of mesodermal tissues in the embryo, and he was a pioneer to grow these 








as non-hematopoietic multipotent progenitors that have the potential to differentiate 
into cell types of the mesodermal lineages like adipocytes, chondrocytes and 
osteoblasts (Chamberlain et al., 2007) (Figure 5). 
The first organ to be studied as a source of MSCs was the bone marrow. Bone marrow 
has been considered the usual source of adult stem cells and is generally used in the 
treatment of haematological diseases, despite its collection being a painful procedure 
and with a low yield of MSC (Haynesworth et al., 1992; Pittenger et al., 1999). 
Haynesworth and colleagues cultured and expanded bone marrow MSCs from the 
iliac crest of human donors and they demonstrated that human bone marrow has also 
cells with osteogenic potential (Haynesworth et al., 1992b). Furthermore, antibodies 
identifying SH-2 and SH-3 as unique cell surface antigens on MSCs were created by 
the same group (Haynesworth et al., 1992a). The ligands of the SH-2 and SH-3 
antibodies were described later by Barry and colleagues as CD105 and CD73, 
respectively (Barry et al., 2001, 1999). Identifying MSCs could be based on ability to 
adhere and proliferate in culture, expression of cell surface markers: CD73, CD90, 
CD105, CD44, CD124 and capacity to produce mesodermal cell lineages in vitro 
(Haynesworth et al., 1992a; Barry et al., 1999, 2001). Pittenger and team isolated 
human bone marrow MSCs from more than 50 donors that were expanded, and were 
differentiating to osteogenic, adipogenic and chondrogenic lineages upon induction. 
The cells showed a normal karyotype and telomerase activity (Pittenger et al., 1999). 
. Due to  the difficulty of the bone marrow collection and the low number of cells 
obtained, other sources of MSCs have been investigated such as dental pulp 
(Gronthos et al., 2000a), skin (Shih et al., 2005), adipose tissue (Rodeheffer et al., 








al., 2004), amniotic fluid (Nadri and Soleimani, 2007), umbilical cord blood (Crisan et 
al., 2008b; Erices et al., 2000), skeletal muscle (Crisan et al., 2008b).  
As stated earlier though human MSCs have been firstly isolated from the bone marrow  
(Caplan, 1991), since then, they have been isolated from the stroma of practically all 
post-natal tissues (Meirelles et al., 2006; Sagar et al., 2018; Zuk et al., 2002). MSCs 
do not have a specific marker that they express and they are a mixed unique 
population of cells (Keating, 2012). The International Society for Cellular Therapy 
(ISCT) set the following characteristics in order to identify an MSC (Dominici et al., 
2006):  
• Be adherent to plastic 
• Be able to self-renew 
• Express the cell surface markers CD105, CD90, CD44 and CD73 
• Do not express the surface markers CD45, CD19, CD14, CD11b, CD34, 
CD79α, and HLA-DR 
• Be able to differentiate into osteocytes, chondrocytes and adipocytes. 
 
Mesenchymal stem cells, apart from their differentiation properties in vitro,  also 
provide in vitro support to hematopoietic stem cells and they are considered of high 
interest for cell therapy due to their regenerative and immunomodulatory properties 
(Majumdar et al., 1998).  MSCs have been already used in almost 1000 clinical trials, 











Figure 5. Mesenchymal stem cell tri-differentiation potential. 
MSCs can differentiate into cell types of the mesodermal lineage such as adipocytes, chondroblasts 





Immunomodulatory properties of MSCs 
 
Mesenchymal stem/stromal cells are extremely valuable for cell therapy due to their 
regenerative and immunomodulatory properties (Kode et al., 2009). The isolation and 
culture expansion of human bone marrow MSCs were reported in 1992 (Haynesworth 








1995 (autologous transplantation) (Lazarus et al., 1995). The MSCs have also been 
used to treat patients with breast cancer (Koç et al., 2000). Clinical trials have been 
performed following infusion procedures. It is now well documented that MSC are 
highly beneficial due to the release of growth factors and cytokines along with 
extracellular vesicles to trigger cell proliferation, prevent apoptosis, and finally improve 
regenerative responses (Shigemoto-Kuroda et al., 2017; Y. Yang et al., 2017). 
Moreover, MSCs can also modulate responses by interacting with different immune 
cells, either by direct contact or through soluble factors released (Figure 6). 
Nevertheless, the process which MSCs follow to prevent inflammation and to boost 
healing is not entirely understood.  
The interaction of MSCs with immune cells including natural killer cells and T cells 
require direct contact through different mechanisms. For example, engagement of  
PD-1 (programmed death 1) and its ligands PD-L1 and PD-L2 is required for inhibition 
of proliferation following signalling by cytokines (Augello et al., 2005). Similarly, the 
production of antibodies by B cells is also inhibited by MSC administration. On the 
other hand, interactions between MSCs and B cells are poorly understood, and 
probably needs other intermediates (Fan et al., 2016). In fact, CD3+ T cells are 
required for B-cell inhibition (Rosado et al., 2014).  
 
The fact that MSCs do not activate the immune system is multifactorial. That could be 
due to the lack of expression of the co-stimulatory molecules CD80 and CD86, needed 
for immune activation, the lack of major histocompatibility complex (MHC) class II 
antigens, and low expression of MHC class I (Krampera et al., 2003; Le Blanc et al., 








for immune modulation by MSCs. The main mediators of MSC-driven immune 
modulation are indoleamine-pyrrole 2,3-dioxygenase (IDO), prostaglandin E2 (PGE2) 
and cyclooxygenase 2 (COX-2) in the presence of pro-inflammatory cytokines (Ryan 
et al., 2007). For example, PEG2  takes part in the production of anti-inflammatory IL-
10 by macrophages (Németh et al., 2009) and prevents differentiation of monocytes 






Figure 6. Immunomodulatory properties of MSCs. 
 Regulation of the immune response by MSCs is a complex mechanism. MSCs can supress naïve and 
memory T cells and inhibit proliferation of B cells.  MSCs reduce IFN-γ production and prevents 
cytotoxicity of Natural Killer (NK) cells through soluble factors. Moreover, MSC can inhibit the 











Regeneration mechanisms of MSCs 
 
In addition to their immunomodulatory properties, MSCs also promote regeneration by 
direct differentiation (although variable) and by promoting the proliferation of host 
endogenous cells through soluble factors release. One of the major mechanisms of 
MSC-driven regeneration described is the promotion of angiogenesis (Amado et al., 
2005). Moreover, the direct injection of perivascular MSC-progenitors into ischemic 
hearts resulted in improvement of vascularization in the cardiac muscle (Chen et al., 
2015). This improvement is believed to be due to the release of different factors such 
as vascular endothelial growth factor (VEGF) which activates angiogenesis as well as 
the nitric oxide synthase (NOS) that blocks fibrosis (Sorrell et al., 2009, Ferrini et al., 
2002). Finally, and importantly, MSCs release exosomes/microvesicles that are non-
cellular transporters of regulatory RNAs, proteins and lipids. These extracellular 
vesicles (EV) can induce proliferation of progenitors and prevent scaring (Lai et al., 
2010; Liu et al., 2018). It has been shown in a model of carbon tetrachloride (CCL4)-
induced liver fibrosis, MSC-derived exosomes alleviated tissue damage (Jiang et al., 
2018). However, whilst the use of MSC-derived EVs for cell therapy seems promising, 
more research is needed to completely appreciate the mechanisms of regeneration. 
For example, EVs are themselves highly heterogeneous, and developing 
specifications for their isolation and characterization constitute important guidelines 









MSCs in clinical trials and alternative approaches to improve clinical 
outcome 
 
Clinical trials and problems 
Over the last twenty years we have seen clinical use of MSCs, and more than 980 
registered MSC trials are listed by the FDA (www.clinicaltrials.gov). The clinical trial 
results have sometimes been inconclusive. For example, in a phase III trial for the 
treatment of steroid-refractory graft-versus-host disease (GVHD) where MSCs 
(Prochymal) were used, there was no significant difference after 28 days when MSC 
treatment was compared to the placebo control (Martin et al., 2010). Nevertheless, the 
stratification of the data showed a better response to MSC treatment by children, which 
then lead to approval of Prochymal in Canada (Reicin et al., 2012). A similar example 
was the use of cardiopoietic primed bone marrow derived MSCs for the treatment of 
ischemic heart failure by Celyad, a Belgium-based company, with promising 
preliminary results. However, further trials revealed no substantial differences 
between placebo and the MSC treatment (Bartunek et al., 2016, 2013). Finally, MSC 
treatment has been approved in other countries as well and it is becoming reality 
despite the controversial results from clinic trials. In Japan, the use of MSCs was 
approved after the Act on the Safety of Regenerative Medicine and the 
Pharmaceuticals, Medical Devices and Other Therapeutic Products Act were 
introduced (Sipp, 2015). More recently in Europe, the European Medicine Agency 
(EMA) recommended the approval of Alofisel as a treatment option for Crohn’s 








One of the main problems regarding MSC therapy is the inconsistent nature of the 
results. The clinical outcomes can be influenced by many variables like the tissue of 
origin, the donor’s gender and the medical history. Other factors that could alter the 
results are the processing of the tissue, the culture conditions, freezing and thawing 
of cells along with the administration routes (reviewed by Galipeau and Sensébé, 
2018). In addition, MSCs are expanded for long periods in order to gain enough cells 
for therapeutics, which might induce changes in gene expression and allows clonal 
selection, therefore affecting biological properties and the heterogeneity of these cells 
(Gomez-Salazar et al., 2020).  
The heterogeneity of MSCs along with the diversity of the tissues they are isolated 
from adds to this complexity in the nature of MSCs. Bone marrow is the most 
commonly used tissue to isolate MSCs followed by adipose tissue and cord blood 
(Gao et al., 2016). MSCs can be obtained from all vascularized organs including 
skeletal muscle (Corselli et al., 2012a; Crisan et al., 2008b), brain (Lojewski et al., 
2015) as well as dental pulp (Shi and Gronthos, 2003a). The MSC’s secretome can 
be influenced by the tissue of origin, as well as from the health status of the donor 
(Kalinina et al., 2015). The importance of the immune system has been highlighted in 
the literature; MSCs obtained from diseased donors have shown not promising 
results , as their angiogenic activity might be affected or decreased, due to the pre-
existing pathology  (Dzhoyashvili et al., 2014). Importantly, recent studies revealed 
that age-related dysfunctions also occurred in dental pulp stem cells (DPSCs) (Yi et 
al., 2017a).  Examples of how the age can affect DPSCs include their cell shape that 
appears enlarged, decreased cell proliferation and altered differentiation potential (Yi 








observed in adult DPSCs in comparison to cells from younger populations (Feng et 
al., 2011). 
Many clinical trials have also been contacted aiming to assess the potential of dental 
pulp stem cells in dentistry.  For example, D’aquino and team were assessing bone 
formation following dental extractions using DPSCs and collagen sponge in 
comparison of collagen sponge alone. They follow it up for three years and they 
identify using radiographic and clinical examination, that vertical repair and complete 
restoration of periodontal tissue were higher at the test site, DPSCS and collagen 
sponge, than the control site, collagen sponge only (d’Aquino et al., 2009b). On the 
other hand, in a more recent clinical  trial by Barbier and team , who also investigated 
socket preservation with the use of DPSC, they  did not reveal any significant 
difference between the testing and control group in a six month follow up period 
(Barbier et al., 2018). Furthermore, clinical trials investigating the success rate of 
periodontal treatment with the use of DPSCs have taken placed too. For example, 
Ferrarotti and team contacted a RCT, randomised control trial, using pulp micro-grafts 
and collagen sponge for the test group and collagen sponge only for the control group. 
They did  follow it up for six and twelve months and clinical and radiographic 
examination revealed a significant periodontal reduction and a  better done defect fill 
in the test group (Ferrarotti et al., 2018). 
As mentioned earlier and as the above examples illustrated, cell therapy can change 
based on processing technical conditions, donor demographics and organ source. 
Therefore, cell therapy using MSCs must be customized to a disease or a specific type 
of injury which might include the pre-conditioning of cells to enhance clinical outcome 








Despite the high use of these cells for cell therapy, the destiny of transplanted MSCs 
is not well documented (autologous, allogeneic, or xenogeneic transplantation). The 
direct contribution of injected MSCs to new tissue formation is little, with only a minor 
proportion of xenogeneic (human) cells engrafting mouse tissues (Chen et al., 2015b), 
and those cells not engrafted being cleared from the tissue 72 h post administration 
(Gholamrezanezhad et al., 2011; Lee et al., 2009; von Bahr et al., 2012). However, 
this clearing of MSCs may be of clinical interest. It has been revealed that dying 
transplanted MSCs inundated by recipient macrophages release immunosuppressive 
soluble factors (Galleu et al., 2017), suggesting that death within host tissues plays an 
important role in the valuable effects of MSCs. 
 
Alternative approaches to improve the clinical use of MSCs 
- Serum free 
The ideal conditions for MSCs to be used for cell therapy include the use of medium 
with no animal products.  Fetal calf serum is one of the most common additives for cell 
culture which properties differ between batches. Passaging of cells, in which 
proteolytic enzymes are used, is essential to obtain this optimal cell expansion; hence 
inducing cell damage (Penna et al., 2015). 
- Oxygen level 
An element that might compromise the therapeutic benefits of MSCs is that MSCs are 
cultured at high oxygen levels. Native perivascular cells (MSC progenitors) tissue 
environments range between 1 and 7% O2; during culture cells sense an oxygen 








eventually leading to senescence (Gomez-Salazar et al., 2020). Indeed, hypoxia has 
been shown to increase proliferation of MSCs (Zhu et al., 2016) although the 
undifferentiated status and multipotency of the cells has not been affected (Basciano 
et al., 2011) 
- Scaffolds and their characteristics   
Different technologies have been proposed to improve the clinical benefit of MSC 
therapy. One of these technologies is, the use of scaffolds that were first seeded by 
MSCs prior to engraftment, and are able to provide a higher regeneration. The method 
of MSC-based scaffolds  has been successfully utilized for bone and cartilage 
regeneration (Kim et al., 2019), as well as for the reproduction of blood vessels 
(Pinnock et al., 2016), cardiac tissue (Ichihara et al., 2018; Rashedi et al., 2017), and 
skeletal muscle (Witt et al., 2017).  An important factor that can influence tissue 
replacement efficiency is the physical features of the scaffolds (Alakpa et al., 2017; 
Jeon et al., 2017; Mouser et al., 2018), as each mechanical property can alter the fate 
of the transplanted cells. For example, concave textured surfaces can be determinant 
to the pace of MSC differentiation into osteogenic and vascular cell lineages in 
comparison with convex surfaces (Graziano et., al 2007). Also, as Alakpa and 
colleagues showed, stiff matrices can lead to MSC differentiation into osteogenic or 
chondrogenic cell lineages  (Alakpa et al., 2016a), while on the contrary softer 
substrates can advocate myogenic development (Gilbert et al., 2010). Cell 
differentiation can be influenced by dimensionality, stiffness, and degradability of the 
matrix (Caliari et al., 2016). 








Another approach to improve clinical outcomes of MSC treatment  is the use of 3-
dimensional printing (Poldervaart et al., 2017) to copy organ microenvironment 
(Fatehullah et al., 2016). Tissue engineering is also useful in order to boost MSC 
residence after administration. With this method MSC-based scaffolds have been used 
along with either biodegradable or non-degradable polymers to form hydrogel matrices 
(Park et al., 2018), which can be boosted with growth factors (Gomez-Salazar et al., 
2020).    
- Cell passages  
When human stem cells cultured in the laboratory for several passages are illustrating 
a typical three-step cell viability profile (Alaminos et al., 2007; Martin-Piedra et al., 
2013);  an initial adaptation to ex vivo cell culture conditions associated with a slight 
decrease of cell viability, following by  an increasing period when cell viability rises and 
cells gain the top cell viability levels (the most appropriate time period for the use of 
the cells in regenerative medicine) and finally a decreasing phase. At this stage the 
cells tend to lose viability and death cell occurs.  
 
 
The expansion of MSCs chooses the fastest growing clones (Selich et al., 2016). 
Additionally, MSC clones have different mesodermal differentiation potentials 
(Muraglia et al., 2000). Regarding the hDPSCs research have shown that eleven to 
fourteen passages of these cells have adequate cell function, proliferation and viability 








- Uncultured cells 
One way for the use of uncultured cells depends on the administration of 
microfragmented adipose tissue, in which the microenvironment of perivascular 
progenitors is maintained  (Vezzani et al., 2019).  This preservation of the niche 
sustains higher secretory activity, releasing abundant cytokines and growth factors 
(Vezzani et al., 2018). In conclusion, transplantation of uncultured cells may be the 
answer to enhance clinical outcome, despite the fact that fewer numbers of cells were 
obtained than in culture conditions and sometimes may be insufficient for conventional 
treatment. This is possible only if we were able to purify the presumptive MSC 
populations that reside in vivo in various organs (James and Péault, 2019;  Murray 
and Péault, 2015). To identify the MSC origin in vivo in various organs, extensive work 




Blood Vessels as a Source of Mesenchymal 
Stem Cells 
 
Although mesenchymal stem/stromal cells have been used in numerous studies and 
clinical trials, the origin of these cells was not known. MSCs are typically isolated by 
adherence to plastic and selection by consecutive passagings. However, the identity 








proposed due to the presence of blood vessels in most organs (Crisan et al., 2008b). 
One of the important observations to identify the MSC progenitor in vivo was the 
relationship between vascular density and MSC yield. Indeed, the higher the number 
of blood vessels in the tissue, the higher the yield of MSCs (da Silva Meirelles et al., 
2008). The attention for the possible MSC progenitors was drawn to blood vessels. 
Indeed, pericytes  in capillaries and adventitial cells in larger vessels were shown to 
be MSC progenitors  (Error! Reference source not found.) (Corselli et al., 2012a; C
risan et al., 2008b).  
 
Pericytes as MSC progenitors  
 
Pericytes (PCs), which are also called mural cells or Rouget cells, are cells embedded 
in the basement membrane of microvessels. Eberth and Rouget were the first to 
describe them  (Rouget, 1873).  Zimmermann called them pericytes due to their 
proximity to endothelial cells (Zimmermann, 1923). Pericytes interact with endothelial 
cells through different signalling pathways including PDGFRβ/PDGF-b, angiopoietin-
1/Tie-2 and TGFβ among others (Armulik et al., 2011).  One of the main functions of 
pericytes, similar to smooth muscle cells of large vessels, are vasoconstriction and 
vasodilation to control vascular diameter and the blood flow in capillaries (Rucker et 
al., 2000). The expression of contractile proteins such as α-SMA, tropomyosin, and 
myosin in pericytes provides evidence of their function. These proteins are also 
produced in smooth muscle cells which leads to confusion between the term of a 
pericyte and a smooth muscle cell. The contractile function of pericytes is strictly 








adrenergic signals produce contraction (Rucker et al., 2000). Pericyte contraction is 
also regulated by oxygen levels. For example, hypoxia increases the contraction of 
pericytes in vitro and CO2 induces relaxation. 
 
 Pericytes in vivo react to vasoactive substances in the skeletal muscle (Hirschi and 
D’Amore, 1996).  Pericytes have also been described to act as progenitors post-injury 
(Dellavalle et al., 2011). 
MSC progenitors were outlined to be in the perivascular niche. However, identifying 
pericytes is not easy due to the lack of specific markers for this cell type. Crisan and 
colleagues identified pericytes as MSC progenitors expressing canonical MSC 
markers, and a set of surface markers including CD146, NG2 and PDGFRβ by 
comparing both in situ and in vitro traits of pericytes and MSCs. A combination of 
markers (CD146+ CD31- CD45- CD34), common between all organs has been used 
to isolate pericytes from various organs (Crisan et al., 2008b).  
 
Whether endogenous pericytes are mobilised upon injury in situ was further studied. 
Lineage tracing experiments showed that skeletal muscle pericytes can differentiate 
into muscle fibres upon injury (Dellavalle et al., 2011) and pericytes that reside in the 
adipose tissue were shown to be adipogenic (Tang et al., 2008). However, more 
recently, the involvement of endogenous pericytes in vivo has been questioned. 
Guimarães-Camboa and team  showed that in mice, pericytes in different organs are 
at the origin of MSCs in culture, but do not contribute to other lineages in aging and 








was not supported by the experimental design. Indeed, Tbx18, used to trace pericytes, 
was questionable since not all pericytes express it. This study suggests however, that 
not all pericytes contribute to regeneration in vivo by directly differentiating into a 
particular cell type. They may have, however, been implicated indirectly in tissue repair 
by releasing pro-regenerative molecules. This is in line with one of our studies which 
found that pericytes are less primitive compared to other perivascular cells and 
express genes more related to their function such as blood flow regulation than to 
“stemness” (Hardy et al., 2017). However, as mentioned, some pericytes act as 
progenitors.  
 
Adventitial cells: another source of MSCs 
 
Large blood vessels, arteries and veins, consist of three layers: tunica intima, tunica 
media and tunica adventitia (in veins there is less smooth muscle and connective 
tissue). The innermost layer, the tunica intima, is comprised of the endothelium and 
connective tissue (mainly collagen, fibronectin and other extracellular matrix 
molecules). The middle layer or tunica media is formed primarily by smooth muscle 
cells and is the thickest layer. The tunica adventitia is the outermost layer and consists 
of connective tissue, fibroblasts, inflammatory cells, vasa vasorum and other cells 
(Moreno et al., 2006) (Figure 7). 
For a long time, the adventitia layer was regarded as a supportive connective tissue 
containing collagen and fibroblasts only. However, in the last years many studies have 








vessel, and showed that it also participates in growth and repair (Majesky et al., 2011). 
The adventitial layer plays key roles in biological processes such as the retrieval, 
integration, storage and release of cellular regulators of vessel wall function. It is the 
most complex layer of the large vessel and is comprised of a variety of cells including 
progenitor cells, fibroblasts, immunomodulatory cells, vasa vasorum endothelial cells 
and pericytes, and adrenergic nerves (Stenmark et al., 2013, 2006). 
Upon injury, cells in the adventitial layer have been proposed to differentiate into 
myofibroblasts, and to migrate to the inner layers of the vessel wall to regulate vascular 
remodelling (Siow et al., 2003; Stenmark et al., 2006). Cells in the adventitia have also 
been described as mediators of remodelling by regulating reactive oxygen species 
(Haurani and Pagano, 2007). Furthermore, the adventitial layer harbours a population 
of cells (CD34+ CD31-) able to differentiate into endothelial cells and participate in 
vessel formation (Hu and Xu, 2011; Zengin et al., 2006). Interestingly, a similar 
population of cells in the adventitia layer  with the following immunophenotype: CD34+ 
CD31- CD146-  shows characteristics of stem cells, and give rise to MSCs in vitro when 
purified by FACS (Corselli et al., 2010a, 2012a). Cells in the adventitia were shown to 
act as progenitors in vivo. For example, resident gli1+ adventitial cells are able to 
differentiate into myofibroblasts after injury in different organs (Kramann et al., 2015) 
and during kidney disease can participate in calcification (Kramann et al., 2016).  
In conclusion, these studies suggest that the adventitia layer acts as a reservoir of 
progenitors revealing heterogeneity of unknown significance. The identification of 
novel markers for adventitial cells is crucial to understand the mechanisms that drive 











Figure 7. MSC progenitors are located in capillaries and large vessels.  






Heterogeneity of perivascular progenitors and derived MSCs 
 
MSCs are heterogenous, due to the fact that they derive from cultures of total cell 
suspensions, even though this high heterogeneity is decreased over time in vitro, 
allowing a better protocol standardization. In fact, clonal analysis of MSC cultures for 
long periods of time has shown that diversity is dramatically decreased after multiple 
passages (Selich et al., 2016). Additionally, MSC clones exhibit diverse differentiation 









The heterogeneity of conventional MSCs also reflects the diversity of their native 
progenitors (pericytes and adventitial cells). Research of perivascular MSCs has 
shown that the phenotype and function of these cells are variable, which also appears 
to be true to different organs and tissues. A developmental grading of pericytes and 
adventitial perivascular cells has been set in human adipose tissue (Hardy et al., 
2017).  
 
Dental pulp stem cell research and potential 
applications   
 
Stem cells have been successfully harvested form different dental tissues such as 
dental pulp (Gronthos et al., 2000a), periodontal ligament (Seo et al., 2004), apical 
papilla, dental follicle (Zhou et al., 2019), periosteum from maxillary tuberosity 
(Giordano et al., 2011) as well as from naturally exfoliated deciduous teeth (Miura et 
al 2003). As stem cells are easily accessible from extracted teeth and with a quite 
minimal intervention, this source of stem cells has been quite popular in the field of 
regenerative medicine (Kim et al., 2012).  
In 2000, Gronthos first identified and isolated odontogenic progenitor cells from the 
dental pulp (Gronthos et al., 2000b). These post-natal dental pulp cells showed 
characteristics of stem cells such as high proliferation capacity and the ability to self-








stem cells (DPSCs) (Gronthos et al., 2000b). The self-renewal-activity of stem cells is 
well known and documented, however  only 1% to 10% of the whole dental pulp cell 
population was identified as stem cells (Gronthos et al., 2002). DPSCs can produce 
more than eighty passages while retaining their stem cell characteristics (d’Aquino et 
al., 2009a). 
Gronthos and team showed that DPSCs can produce dentine-pulp like complex after  
transplantation into immunodeficient mice (Gronthos et al., 2000a). The dentin / pulp 
like complex consisted of mineral matrix with tubules lined with odontoblasts as well 
as fibrous tissues with blood vessels in a similar arrangement to human tooth dentin -
pulp complex (Gronthos et al., 2000a). The ability of DPSCs to differentiate into cells 
with osteogenic, adipogenic, chondrogenic, neurogenic and angiogenic characteristics 
was shown by Gronthos and other teams (Gronthos et al., 2000b; Lan et al., 2019; 
Saito, 2015; Suchánek et al., 2010; Yu et al., 2007).  
 
DPSCs can easily be obtained and due to the fact that their biological function is to 
form mineralised hard tissue during tooth development, there is a large amount of 
research investigating their ability for osteogenic differentiation (Kim et al., 2012; 
Awais et al., 2020). Indeed, DPSCs have been shown to express in culture bone 
markers including: bone sialoprotein, type I collagen, osteonectin, alkaline 
phosphatase and osteocalcin (Buchaille et al., 2000; Kuo et al., 1992; Monterubbianesi 
et al., 2019). Paino and team illustrated the successful fabrication of woven bone-like 
structure derived from DPSCs after four days in culture. Following that, the woven 








transplantation led to the production of highly vascularised bone tissue  (Paino et al., 
2017). Similarly, Ikeda and team observed bone tissue formation from cultured 
hDPSCs with recombinant human BMP-2 (rhBMP-2) (Ikeda et al., 2011). Ikeda and 
team suggested the treatment with rhBMP2 in osteogenic medium could potentially 
lead in using dental mesenchymal tissues as an effective source of cells for bone 
tissue engineering (Ikeda et al., 2011). 
 
On the other hand, the chondrogenic differentiation of DPSCs was not equally 
promising and quite low compared to mesenchymal stem cells deriving from bone 
marrow (Balic et al., 2010). More recently, Longoni and team showed that the dental 
pulp is a valuable stem cell source for the regeneration of fibrocartilaginous tissues, 
including condylar cartilage, for TMJ regeneration  (Longoni et al 2020). 
 
Regarding adipogenesis, Gronthos and colleagues stated that they were unable to 
develop adipocytes using DPSCs (Gronthos et al., 2000b). However, two years later, 
this group reported that it was possible to induce DPSCs to form characteristic oil red 
O-positive lipid-containing adipocytes using a more potent adipogenesis-inductive 
culture medium (Gronthos et al., 2002), these data were not reproduced by others 
(Monterubbianesi et al., 2019). 
Taking into consideration the neural crest origin of the dental pulp, it comes as no 
surprise that DPSCs exhibit intrinsic neurological characteristics and can differentiate 








Kaukua and team showed that a sub-population of DPSCs have glial cell origin 
(Kaukua et al., 2014). Young and team have suggested that dental pulp may give a 
likely alternative source of stem cells for replacement therapy following central nervous 
system damage (Young et al., 2013). This was shown initially in an animal study by 
Yu and team  (Yu et al., 2002). The potential of DPSCs to differentiate into neuron-like 
cells was also supported by Rafiee and team (Rafiee et al., 2020). 
By the viral induction of Oct3/4, Sox2, Klf4 and c-Myc transcription factors the 
pluripotency of dental pulp cells was proven (Tamaoki et al., 2010). However, the 
transcription factors work by integrating to the host DNA and that could trigger tumour 
genesis (Tamaoki et al., 2010).  
As DPSCs have the ability  to differentiate after cryopreservation (Zhang et al., 2006), 
private companies have pioneered dental stem cell banks in order to use these cells 
in the future (Kim et al., 2012). 
DPSC potential clinical applications  
 
When transplanted with hydroxyapatite/tricalcium phosphate (HA/TCP) or nanofibrous 
poly-L-lactic acid (PLLA), DPSCs differentiated into odontoblasts and formed dentine 
in immunodeficient mice (Lee et al., 2011; Sun et al., 2014; Wang et al., 2010).  The 
use of the DPSCs was investigated by Gandia and team for the treatment of 
myocardial infarction in rats (Gandia et al., 2008a). DPSCs were injected 
intramyocardially in rats in which myocardial infarction was induced. That lead to an 
improvement in cardiac function and reduction of the infarct size four hours later along 









The ability to treat muscular dystrophy using DPSCs in golden retrievers was  
investigated by Kerkis and team (Kerkis et al., 2008). The results of the above research 
were promising as clinical improvement was noted in one dog which had monthly 
arterial injections (Kerkis et al., 2008).  
 
Clinical studies have shown the successful use of DPSCs cells in oro-maxillo-facial 
(OMF) bone repair (d’Aquino et al., 2009). They have used DPSCs on collagen sponge 
scaffolds and they revealed that DPSCs have good adherence and good vascular 
bone tissue formation on microconcavity surface textures. These outcomes enforce 
the concept that DSPCs cells can be used for OMF bone repair and tissue engineering 
(d’Aquino et al., 2009). 
Other studies suggested that DPSCs also have the potential to help with corneal 
reconstruction.  Indeed, Gomes and team demonstrated the successful ocular surface 
recontraction in an animal model of complete limbal stem cell deficiency with the 
transplantation of human DPSC (Gomes et al., 2010; Monteiro et al., 2009). 
 
Neurogenesis was also investigated by Nakashima and colleagues. Acceleration of 
neovascularisation at the ischemic zone as well as neuronal regeneration and 
decrease of the ischemia and improvement in the functional outcome was seen 
following the transplantation of human DPSCs into the striatum of the ischemic rat 









There is an increased interest and many attempts have been carried out to generate 
neural cells using adult stem cells from various resources (Kim et al., 2012). All trials 
are aiming to regenerate nerves, which could be used for the treatment of nerve 
injuries and neurodegenerative disorders.  Yang and team investigated the potential 
use of DPSCs on repairing the complete transection of rat spinal cord  (Yang et al., 
2017). Song and team investigating potential therapies for degenerative diseases, 
showed both in vivo using a rat stroke model and in vitro in an ischemia model that 
DPSCs might be a more promising source in cell therapy for ischemic stroke than 
human bone marrow mesenchymal cells (Song et al., 2017). In another study, where 
a rodent ischemia model was used, Nito and team demonstrated that DPSC transplant 
helped to improve functional recovery of brain damage after acute cerebral ischemia 
(Nito et al., 2018).   
Although some successful methods have been reported and set criteria have been 
suggested, up to this moment there is no definitive path for the trans-differentiation of 
MSCs to neural cells (Hernández et al., 2020; Krabbe et al., 2005).  
 
The brain neural stem cells have been shown to express nestin (Takeyasu et al., 
2006). Nestin is a neural stem cell marker which is expressed at the first 
developmental stages and then downregulated in mature tissues  (About et al., 2000). 
The ability of the DPSCs to express nestin as well as GFAP (glial fibrillary acid protein) 
was shown by Gronthos and team  (Gronthos et al., 2002). Also, the differentiation of 








reported (Sasaki et al., 2008; Kim et al., 2012). Under neural differentiation conditions, 
in vitro, DPSCs have been tested positive for  the following neuronal markers : 
calcium/calmodulin- dependent protein kinases II, GFAP, TUJ1 (β tubulin III) and 
tyrosine hydroxylase (Takeyasu et al., 2006). Further research performed by Arthur 
and team showed that adult human DPSCs developed a neuronal morphology and 
expressed neuronal specific markers at gene and protein levels (Arthur et al., 2008). 
They also found that these cells had the ability to produce a sodium current consistent 
with functional neuronal cells when exposed to neuronal inductive media (Arthur et al., 
2008). The same team reported secreted factors which coordinate axon guidance 
while using human DPSCs in an avian embryonic model (Arthur et al., 2009).  
 
The DPSCs as a new source of mesenchymal stem cells could be a tool for 
regenerative dentistry and medicine. DPSCs have demonstrated ability to influence  
angiogenesis (Mattei et al., 2021).  Angiogenesis is the formation of new vessels from 
pre-existing vessels. It is controlled by mutual interactions between perivascular and 
endothelial cells and has a pivotal role in tissue repair and regeneration (Pittenger et 
al., 2019). Perivascular and endothelial cells can form a vascular network in vitro and 
in vivo. Characterising these dental pulp perivascular cells and exploring their ability 
towards differentiation in vitro will help us to understand their mechanism and the 











Characterising and isolating the dental pulp stem cells (DPSCs) will provide further 
understanding of the potential of these cells in craniofacial regeneration in the event 
of an injury. Previous published work, including ours, has shown that perivascular cells 
can be prospectively purified from multiple human organs including placenta, 
pancreas, fat and muscle and demonstrated their multilineage developmental 
potential, characteristic of mesenchymal stem cells (MSCs) (Corselli et al., 2010b; 
Crisan et al., 2008c). Pericytes are therefore of potential interest for regenerative 
medicine. 
 
Teeth, which are lost in the course of normal development (primary teeth), and 
commonly extracted in young adults (third molar or wisdom teeth), can be a source of 
such autologous stem cells, especially since dental pulp is rich in blood vessels. 
Pericytes in the dental pulp might originate from the migrating cranial neural crest cells 
(Nayak et al., 1988; Zhao and Chai, 2015) in contrast to pericytes isolated from other 
tissues, which originate from the mesoderm (Téclès et al., 2005). This led to the 
hypothesis that the dental pulp pericytes exhibit different characteristics and 
differentiation potential. Regenerative DPSCs and their mode of action are not fully 
identified and characterised in situ. Evidence from literature suggests that these cells 
reside within the blood vessels. To test this, my overall objective was to identify and 
characterise human dental pulp perivascular cells in situ and their mesenchymal 
differentiation potential in vitro upon isolation and culture. 
 
 









Identify, localise and characterise mesenchymal perivascular stem cells in human 
dental pulp (molar and premolar). To do this,  
a) I performed immunohistochemistry on frozen sections using combinations of 
markers that distinguish pericytes, endothelial cells and neural cells. 
b) I performed flow cytometry to characterise, quantify and purify perivascular cells 
from the dental pulp. 
c) I established perivascular cell lines in culture and I investigated their differentiation 
potential in vitro. 
My approach relied first on immunohistochemistry experiments to determine the 
presence of cell surface markers that could be utilized to sort dental pulp pericytes. 
Following the above, I then confirmed that sorted dental perivascular cells could be 
expanded in culture and are multilineage mesodermal progenitors. 
 
Hypothesis  
Dental pulp pericytes are heterogeneous and they are endowed with the ability to 
differentiate into different lineages.   
 
Aim 1: Characterise dental pulp perivascular cells by immunohistochemistry 
Markers of pericytes (αSMA, PDGFRβ, LepR, CD107a, CD146, NG2), adventitial cells 
(CD34), MSCs (CD29, CD44, CD90), endothelial cells (CD54, CD34, UEA-1, vWF) 








were further analysed on a Zeiss Observer inverted microscope and imagine was 
taken. 
Aim 2: Purify dental pulp perivascular cells by flow cytometry 
Multi-colour fluorescence-activated cell sorting, FACS, was used to purify to 
homogeneity pericytes and adventitial cells from the dental pulp. Yield and purity post-
sort were assessed by FACS re-analysis prior to culture. 
Aim 3: Determine the developmental potential of dental pulp perivascular cells, 
in vitro 
The ability of cultured PCs, ADCs, NG2+ PCs and NG2- PCs (6 to 8 passages) to 
differentiate into adipogenic, osteogenic and neurogenic cell lineages were evaluated 

































Dental pulp extraction 
 
Dental pulp will be harvested from impacted third molar teeth in patients younger than 
30 years, at the Oral Surgery Department under local anaesthetic at the Edinburgh 
Dental Hospital. Following extraction, all periodontal tissue will be removed gently from 
the root surface with Gracey curettes and the teeth will be split by placing a groove 
longitudinally along the mesial and distal surfaces of the root and crown. Within two 
hours the tooth will then be split mechanically with a mallet and chisel and the dental 









MSC isolation and cell culture  
 
Following the above procedure, the dental pulp was digested with collagenases I, II, 
and IV (final concentration in DMEM +20% fetal bovine serum (FBS)) at 37 ˚C for 45 
minutes under gentle agitation in a water bath at 370C.  
After the tooth pieces were removed and washed with phosphate buffered saline 
(PBS) + 2% FBS. All material obtained was centrifuged at 1500 rpm for 10 minutes. 
The supernatant was removed, PBS + 2% FBS was added and homogenised. The 
samples were then filtered using strainers (100 μm, 70 μm and 40 μm pore size) and 
again centrifuged at 1000 rpm for 10 minutes. Part of the samples were cultured 
(MSCs) and another part was submitted to FACS sorting. For MSCs, cells were plated 
into flasks containing DMEM high glucose supplemented with 1% penicillin-
streptomycin and 20% FBS. Cultures were stored in an incubator at 37 °C with 5% 
CO2. The culture medium was replaced twice a week. When the cultures reached 
approximately 80–90% confluence, cells were dissociated using 0.25% trypsin/EDTA 




After removing the dental pulps, the samples were frozen in Tissue Freezing Medium 
(Triangle Biomedical Sciences) and cryosectioned at 10-µm thickness. Tissue 








then washed with PBS three times for 5 minutes. Sections were next incubated with 
5% goat serum (Gibco) in PBS (blocking solution) for 1 hour at room temperature (RT) 
in a wet chamber to prevent antibody non-specific binding. Excess blocking solution 
was removed from the slides and the tissue sections were incubated with primary 
antibody (Table 1) overnight (ON) at 4˚C.  
 
 
Marker Supplier Catalog Dilution 
CD34 BD Pharmingen 550390 1:100 
CD146 BD Pharmingen 550314 1:100 
PDGFRβ Abcam ab32570 1:100 
LEPR Abcam ab5593 1:100 
NG2 Abcam ab104535 1:100 
CD44 BD Pharmingen 550392 1:100 
CD90 BD Pharmingen 555593 1:100 
CD54 Abcam ab2213 1:100 
ALP R&D Systems MAB1448 1:100 
CD29 BD Pharmingen 09351D 1:100 
αSMA Sigma Aldrich F3777 1:300 
vWF Abcam ab8822 1:200 
CD56 
(Biotinylated) 
Ancell 208-030 1:250 
UEA-1 
(Biotinylated) 
Vector B1065 20806 1:200 









Table 1. Primary antibodies and isolectin used for detection of perivascular cells in human 
 
 
The following day, sections were washed twice with PBS for 5 minutes. Appropriate 




Marker Supplier Catalog Dilution 
Alexa Fluor 488 Invitrogen A21428 1:250 
Alexa Fluor 555 Invitrogen A21422 1:250 
Alexa Fluor 488 
conjugated 
Streptavidin 
Life Technologies 532354 1:250 
 
Table 2. Secondary antibodies used to detect primary antibodies 
 
 
When two antibodies were used simultaneously, the sections were incubated for 1 
hour at RT with a second primary antibody that was already conjugated. After two 
additional washes with PBS, the sections were then stained with 4’,6-diamidino-2-
phenylindole (DAPI, 1:2000, Molecular Probes) for 5 minutes at RT to visualize nuclei. 
Coverslips were mounted with Gel/Mount mounting medium containing anti-fading 
agents (Biomeda Corp.).  
If the primary antibody was biotinylated, a step of blocking with avidin and biotin was 
performed prior to blocking with serum. Tissue sections were analysed on a Zeiss 











Fluorescence-activated cell sorting and cell culture  
 
Freshly digested dental pulp cells were washed with PBS. The tissue was next treated 
according to our established protocol (Corselli et al., 2012a; Crisan et al., 2008b). Cells 
were washed and stained with fluorescent antibodies for 30 minutes at 4 ˚C. 
 
 
Marker Fluorochrome Supplier Catalog Dilution 
CD146 BV711 BD Horizon 563186 1:100 
CD31 V450 BD Horizon 561653 1:100 
CD34 PE BD Pharmingen 555822 1:100 
CD45 V450 BD Horizon 560368 1:100 
CD56 V450 BD Horizon 560360 1:100 
NG2 FITC Millipore Ab532044 1:100 
 
Table 3. Antibodies used for cell sorting 
 
 
Cells were then washed with PBS+2% FBS and resuspended in 200 µl PBS+2% FBS. 
The cell suspension was filtered with 40 µm cell strainer. A FACS Aria dual-laser 








cells (CD146-CD31-CD34+CD45-CD56-); pericytes (CD146+CD31-CD34-CD45-
CD56-); NG2 positive pericytes (CD146+CD31-CD34-CD45-CD56-NG2+) and NG2 
negative pericytes (CD146+CD31-CD34-CD45-CD56-NG2-). DAPI was used to 
exclude dead cells.  
Sorted cells (adventitial and NG2 positive pericytes and NG2 negative pericytes) were 
cultured at 37˚C, 5% CO2 in Endothelial Cell Growth Medium 2 (EGM-2, Cambrex 
Bioscience Inc.) on 96-well tissue culture plates coated with 2% gelatin (Calbiochem) 
at 10,000 cells per well. The culture medium was replaced twice a week. When the 
cultures reached approximately 80–90% confluence, cells were dissociated using 
0.25% trypsin/EDTA and re-plated (passage 1). After passage 1, medium was 
changed to DMEM high glucose (GIBCO) with 20% FBS and 1% penicillin-
streptomycin.  
 
Osteogenic differentiation  
 
Cells were plated at a concentration of 25,000 cells/cm2 in triplicate in 24-well plates. 
The cells were kept in an incubator at 37 °C with 5% CO2 until reaching 80% 
confluence. The osteogenic differentiation medium contains DMEM supplemented 
with 10% FBS, 1% penicillin/streptomycin, 50ug/ml L-ascorbic acid (Fisher Biotech), 
100mM ß-glycerophosphate (Sigma), and 100nM dexamethasone (Sigma). For 
control, cells were cultured with DMEM supplemented with 10% FBS without 








culture medium was replaced every two to three days. Cultures were checked at day 
7, 14, 21 and 28. 
To evaluate the presence of calcium crystals, cells were washed with PBS and fixed 
with 4% PFA for 15 minutes at RT at different time points (7, 14, 21 and 28 days). After 
fixation the samples were rinsed with distilled water and incubated for 15 minutes in 
Alizarin Red S (Sigma-Aldrich). Excess Alizarin Red was removed with three washes 




Quantification of Alizarin Red S in osteogenic 
differentiation 
 
To quantify alizarin Red S in osteogenic differentiation, a solution of 10% acetic acid 
was added to alizarin red-stained cells and incubated with shaking for 30 minutes.  
Following that, the acetic acid was removed along with the cells by scraping the bottom 
of the well and transferred into a 1.5 ml Eppendorf tube. On to the next step, the tubes 
were heated for 10 minutes at 85°C, and were transferred to ice to cool down for 5 
minutes. The tubes were then centrifuged for 10 minutes at 21952 RCF, next 500ul 
were taken into a new tube and then 200ul of ammonium hydroxide was added. After 
mixing the tubes, 50ul were transferred into a well of a 96 well plate, then absorbance 









Adipogenic differentiation  
 
Cells were plated at a concentration of 25,000 cells/cm2 in triplicate in 24-well plates. 
The cells were kept in an incubator at 37 °C with 5% CO2 until reaching 80% 
confluence. The adipogenic differentiation medium contains DMEM supplemented 
with 10% FBS, 1% penicillin/streptomycin, 0.5 mM of 1-methyl-3-isobutylxanthine 
(Sigma), 1uM dexamethasone (Sigma), 0.01 mg/ml insulin (Cell Sciences), and 0.2 
mM indomethacin (Sigma). For control, cells were cultured with DMEM supplemented 
with 10% FBS without differentiation factors or inducers. The cultures were maintained 
for 28 days, and the culture medium was replaced every two to three days. Cultures 
were checked at day 7, 14, 21 and 28. 
To evaluate the presence of lipid vacuoles, cells were washed with PBS three times 
and fixed with 4% PFA for 15 minutes at RT, following by washing with 70% ethanol 
for a few seconds. The samples were incubated with Oil Red O (Sigma-Aldrich) for 20 
minutes at RT at different points (7, 14, 21 and 28 days). Afterwards, the samples 
were washed with 70% ethanol and distilled water.  
 
Neurogenic differentiation  
 
Cells were seeded at 25,000 cells/cm2 in 24-well tissue culture plates and coated with 
laminin (LN511, Biolamina) 10μg/ ml final concentration ON at 4°C. Wells were 
washed gently with PBS (with Ca++ and Mg++) prior adding the neurogenic medium. 








ug/ml streptomycin, 1 x B27 supplement, 20mg/ml epidermal growth factor (EGF) and 
40mg/ml basic fibroblast growth factor (bFGF). Neurogenic medium was prepared the 
same day and it was replaced twice per week for 28 days. For control, cells were 
cultured with DMEM supplemented with 10% FBS without differentiation factors or 
inducers. 
 
At the final day, day 28, the medium was removed from the wells. Wells were washed 
once with PBS and 4% PFA for 10 minutes was added. Wells were then washed twice 
with PBS. Following that 0.5% triton in PBS for 3 minutes was added and was removed 
by washing twice with 0.2% BSA in PBS. Wells were blocked with 10% goat serum for 
1 hour at RT, the excess of serum was removed and β tubulin III was added ON at 
4˚C. (TUJ1/ β tubulin ΙΙΙ MAB1195, 1:1000). The following day β tubulin III was 
removed, wells were washed 3 times for 10 minutes with 0.2% BSA and the 
appropriate conjugated secondary antibodies were used (Table 2). After two additional 
washes with PBS, the wells were stained with 4',6-diamidino-2-phenylindole (DAPI, 
1:2000, Molecular Probes) for 5 minutes at RT to visualize nuclei. Wells were analysed 
on a Zeiss Observer inverted microscope. 
 
Imaging  
Images were taken using a wide field Zeiss Observer microscope with a Colibri7 LED 
light source (Zeiss). A Hamamatsu Flash 4.0 v3 camera (Hamamatsu Photonics) was 
used for monochromatic fluorescent and brightfield images and an inverted widefield 
Live Imaging Nikon TiE for angiogenesis assays. Magnifications of 4X 10X, 20X and 









Statistical analysis  
Data were analysed using GraphPad Prism software. Number of biological replicates 
is indicated as (n). Every biological replicate has 3 technical replicates. Shapiro- Wilk 
normality test was performed in all data sets. I used unpaired T-test with Welch’s 
correction, and when appropriate, paired T-test.  For more than 2 groups analysed, I 
used One-way Anova with Tukey post-test for multiple comparisons (parametric), or 




























Participants / Demographics  
 
Participants were identified at the new patient consultation clinic at the Oral Surgery 
department at the Edinburgh Dental Institute by a single clinician (EB). Information 
leaflets were given to the patients and they were asked if they wish to participate in 
the study (appendix section).  
Inclusion criteria were:  
• Participants should be younger than 30 years of age.  
• Attending for removal of a non-carious tooth under local anaesthetic.  
• Non-surgical extraction 
The day of the appointment, patients were re-consented for the procedure of non-
surgical removal of treated tooth, and they confirmed their decision to participate in 








following by the signing of the participant consent form (appendix section). The 
consent form was next signed by the clinician treating the patient at the day.  
The collection of teeth started in the June 2016 and completed in April 2019.  
Fifty-four participants, twenty-one males and thirty-three females, were recruited with 
an age range of 20 to 29 years. The mean age for the total sample was 24.5 years 
(male 23.4 years, female 25.2 years). From the sample of 54 subjects 83 teeth were 
collected. From these, 31 teeth were from the male subjects and the remaining 52 
were from the female subjects (Table 5). Only four out of the 83 teeth were premolars 
(3 upper premolars and 1 lower premolar which were extracted for orthodontic 
preposes). Seventy-nine teeth were third molar teeth which were extracted due to 
pericoronitis. From the majority of the participants one or two teeth were extracted at 
the same appointment, 29 and 22 teeth respectively. Three subjects were the 
exception as four teeth were extracted from one participant and three teeth from the 
other two participants.   49% of the extracted teeth were maxillary teeth (41 maxillary 
teeth and 42 mandibular teeth) (Figure 8). Seven of the above teeth were not used 
due to failure to remove the dental pulp atraumatic (four teeth), incomplete extraction 
/ fracture of root (two teeth) and due to early detection of caries (one tooth).  
 
 Participant number 
 
Mean Age (years) Teeth number 








Females  33 25.2 52 
Total  54 24.5 83 
 























Characterise dental pulp perivascular stem cells by 
immunohistochemistry  
 
Identification and characterisation of pericytes in the dental pulp 
We used immunohistochemistry and various combinations of markers such as αSMA, 
CD146, PDGFβ, LepR, CD107a to identify and characterise pericytes in the human 
dental pulp. These markers were previously used by our laboratory to identify pericytes 
in other human organs (Corselli et al., 2010b; Crisan et al., 2008c, 2012a; Xu et al., 
2019, 2020). Since pericytes are localised around the microvasculature we used 
CD34, UEA-1, vWF and CD54 to mark endothelial cells. The detection of the 
endothelial cell markers showed the presence of a developed vascular network in the 
human dental pulp independent of the tooth types tested.  
 
We examined five human dental pulp samples in total, three molars and two 
premolars, from both female and male subjects aged 20 to 29 years. In the human 








surrounding capillaries (diameter < 10μ) and arterioles and venules (diameter 10 to 
100μm). For example, I found that αSMA expression pattern in the dental pulp is 
similar to that in other organs. Indeed, αSMA is expressed in larger vessels (Figure 
9A-F) and only in a few capillaries (Figure 9C). I have also investigated the expression 
of leptin receptor (LepR). Also known as CD295 and OB-R, LepR is  a type I 
transmembrane glycoprotein, class I cytokine receptor (Zhang et al., 1997). LepR is 
expressed in microvessels, in perivascular cells, in human adipose tissue (Corselli et 
al., 2013) and in healthy and inflamed human dental pulp (Martín-González et al., 
2013). Although Martín-González and team showed that LepR is expressed in human 
dental pulp,  they did not identify in which cell type LepR is expressed.  (Martín-
González et al., 2013). In line with this, we confirmed that LepR is indeed expressed 
in healthy human dental pulp and we have identified LepR expression in bigger 
vessels (arterioles and venules) (Figure 10 B, D, E) but not always in capillaries (Figure 
10 A, B, C, D).  CD107a, a lysosomal membrane protein -1 (LAMP), with functions in 
cancer metastasis and in immune response (Eskelinen et al., 2003), has also been 
shown by our laboratory to be expressed in perivascular cells in human adipose tissue, 
with only 82% of pericytes and 32% of adventitial cells being positive (Xu et al., 2020), 
highlighting the heterogeneity within these cell compartments. Research from our 
team had further demonstrated that CD107a- pericytes have higher osteogenic ability 
(Xu et al., 2020). We have tested CD107a in the human dental pulp, and we found 
that its expression is associated with pericytes in microvessels (Figure 10 E). 
The CD146 marker was also used in our experiments. CD146 or M-CAM or MUC18 is 
a membrane glycoprotein which is essential for the interaction between endothelial 








is  expressed by human pericytes and some endothelial cells (Crisan et al., 2008c), 
smooth muscle cells, B and T lymphocytes (Covas et al., 2008; Tormin et al., 2011) 
as well as in glioma stem cells (Yawata et al., 2019). We have shown that CD146 is 
expressed in pericytes in the dental pulp in both capillaries and microvessels (Figure 
11 A-C) as well as neural cells (Figure 11 A).  Other markers we used that are 
expressed by pericytes are platelet derived growth factor receptor β (PDGFRβ) and 
neural glial antigen 2 (NG2). Research has revealed the PDGFRβ fundamental role 
during capillary sprouting recruiting pericytes due to PDGFβ/PDGF-b signalling as well 
as the PDGFRβ expression on smooth muscle cells, glial cells and interstitial 
fibroblasts (Bonner, 2004; Crisan et al., 2008c; Hellstrom et al., 1999; Robbins et al., 
1994; Stapor et al., 2014). In the dental pulp, we found that all perivascular cells 
express PDGFRβ irrespectively of the blood vessel type (Figure 11 D, E, F). 
NG2 also known as chondroitin sulphate proteoglycan 4, regulates cell proliferation 
and migration at vasculogenic stage and binds to collagen α2 and β1 integrin (Stallcup 
and Huang, 2008). NG2 is expressed on pericytes in the arterial system as well as on 
macrophages, glial cells and different tumour cells  (Crisan et al., 2009; Murfee et al., 
2006, 2005).  As illustrated in figure 12, we found that not all pericytes express NG2. 
Indeed, NG2 is expressed in human dental pulp pericytes in capillaries and 
microvessels (Figure 12 A-D) but is absent in venules (Figure 12 A, B).  
In conclusion, human dental pulp pericytes express multiple cell markers that include 
NG2, PDGFRB, αSMA, LepR and CD107 of which combination changes based on the 
blood vessel type where they reside. We here confirm that human dental pulp 
perivascular cells do not express the endothelial cell markers von Willebrand factor 








identify the molecular signature of PCs in dental pulp as CD146+ αSMA+/- NG2+/- 
















Figure 9. Expression of αSMA on human dental pulp frozen sections in combination with 
endothelial cell markers UEA-1 (A), vWF (B), CD34 (C), CD54 (F) and pericyte markers ALP (D) 
and CD146 (E).                                                                                      
n=5 teeth tested (molars/premolars= 3/2, males/female=2/3). All nuclei are stained by Dapi (blue). ECs: 
endothelial cells PCs: pericytes, a: arterioles, c: capillaries, v: venules. Scale bar= 10μm. (A ,C X10 B 









Figure 10. Expression of LepR and CD107a on human dental pulp frozen sections in combination 
with endothelial cell markers vWF (A, B), UEA-1 (E) and pericyte marker αSMA (C, D)  
n=2 teeth tested, molars (A, D, E) /premolars (B, C) = 1/1, both females. All nuclei are stained by Dapi 
(blue). ECs: endothelial cells PCs: pericytes, a: arterioles, c: capillaries, v: venules, a/v: arterial or 













Figure 11. Expression of CD146 and PDGFβ on human dental pulp in situ in combination with 
αSMA pericyte marker (A, D) and endothelial cell markers vWF (C, F) and UEA-1 (B, E). 
 n=2 teeth tested, both molars and from male subjects. All nuclei are stained by Dapi (blue). ECs: 
endothelial cells PCs: pericytes, a: arterioles, c: capillaries, v: venules a/v: arterial or venule. Scale bar= 










Figure 12. Expression of NG2 on human dental pulp frozen sections in combination with 
endothelial cell markers vWF (A, B), UEA-1 (C) and pericyte marker αSMA (D). 
Immunohistochemistry showing pericyte heterogeneity, NG2+ and NG2- pericytes. 
 n=4 teeth tested (molars/premolars= 3/1, males/female=2/2). All nuclei are stained by Dapi (blue). ECs: 
endothelial cells PCs: pericytes, NC: neural cells a: arterioles, c: capillaries, v: venules. Scale bar= 










Pericytes in the dental pulp co express MSC markers  
Since pericytes in other human organs express classical MSC markers both in situ 
and in culture (Crisan et al., 2012a),  we next examined some of these MSC markers 
including CD29, CD90 and CD44 by immunohistochemistry in the human dental pulp 
in combination with αSMA and vWF. We found that all three markers tested are 
expressed in human dental pulp and that their expression coincides with that of αSMA 
(Figure 13 A, B, D). CD44 was not expressed from all endothelial cells as there is no 












Figure 13. Immunohistochemistry on human dental pulp using antibodies against MSCs, 
pericytes, and endothelial cells. MSC biomarkers: CD29 (A, D), CD90 (B), CD44 (C), pericyte 
biomarker αSMA (A, B, D) and endothelial cell marker vWF (C) were used. 
 Blue marks DAPI staining of cell nuclei. ECs: endothelial cells PCs: pericytes, a: arterioles, c: 















Identification of neural cells in the dental pulp  
To identify nerve cells, we used neuronal markers CD56 and vimentin, and combined 
with the pericyte markers NG2, CD146, LepR and αSMA in both males and females 
molar and premolar teeth. CD56 or neural cell adhesion molecule (NCAM) is a marker 
for natural killer, neural and skeletal muscle associated satellite cells (Plappert et al., 
2005). CD56 is a member of the immunoglobulin family. CD56 is expressed on 
neurons and glia in both the developmental and mature nervous system and it has a 
key factor in synaptic plasticity and memory formation of the mature nervous system 
(Fields and Itoh, 1996; Jessell, 1988).  Vimentin is an intermediate filament protein 
which can be found in different types of immature cells in the central nervous system 
(CNS) and body such as neuroepithelial cells. It can also be found in mature cells in 
the CNS such as: endothelial cells, smooth vascular musculature, fibroblasts (Harvey 
B. and Flores-Sarnat, 2013). 
Interestingly we found that the expression of neural markers coincides with the 
pericyte expression of LepR, NG2 and CD146 pericyte markers as shown in Figure 14 
A, B, C and E. It is important to highlight that not all pericyte markers overlap with 
neural cell markers. Indeed, we found that neither CD56+ nor vimentin+ neural cells 














Figure 14. Immunohistochemistry of human dental pulp frozen sections with neural cell, 
pericytes and endothelial cells markers. Neuronal cell biomarkers: CD56 (A-E), vimentin (F), 
pericyte biomarkers: LepR (A), αSMA (B, F), NG2 (C, E), and pericytes/endothelial cell marker 
CD146 (D). 
 molar/premolar=2/1, male/female=2/1. Blue marks DAPI staining of cell nuclei. ECs: Endothelial cells, 









Purification of dental pulp perivascular cell subsets 
by flow cytometry 
 
 To study the biological function of various perivascular cell populations, we next 
dissociated the dental pulp in single cell suspension and purified these cells by flow 
cytometry.  Viable cells were selected while excluding debris, dead cells and doublets 
(Figure 15 A). CD56+ cells were then gated out of dental pulp cell suspensions to 
avoid contamination due to the overlap with pericyte markers. In order to remove 
endothelial cells and hematopoietic cells we used negative selection for CD31 and 
CD45 (Figure 15 B, C). Pericytes were then identified by the expression of CD146 
(Figure 15 D). We repeated this experiment three using 4 samples obtained from 1 
male and 3 females. 
 
Figure 15. Pericyte isolation from human dental pulp. 
(A, B &C) Perivascular cells are identified as live single cells, negative for CD31, CD45, CD56. (C) 








Adipogenic, osteogenic and neural differentiation of MSCs and 
pericytes from human dental pulp      
 
We found that perivascular cells in situ co express MSC markers. These observations 
lead us to address the question whether pericytes can be cultured in vitro and 
differentiate towards MSC lineages. To do this, we used adipogenic and osteogenic 
media to induce adipogenic and osteogenic differentiation in our CD146+ pericytes 
and MSCs and check their ability at various time points such as 7, 14, 21 and 28 days. 
Results at day 28 are shown in figure 16. We found that both MSCs and CD146+ 
pericyte cultures after the use of adipogenic medium were unable to accumulate lipid 
droplets at any time points studied (Figure 16 A). Both cell populations are sharing 
osteogenic differentiation abilities. Indeed, after the induction of the osteogenic 
medium, evidence of calcium deposits were visible in both cell populations (Figure 
16B).  In addition, we also found that pericytes and neural cells share markers in situ 
suggesting a link between pericytes and neural system. Interestingly when neurogenic 
differentiation was induced in MSCs and CD146+ pericytes, tubulin β III expression 
was detected by immunofluorescence. However, cell morphology was not indicative 
to neural cells. Cells appeared with a flat, large elongated body and with long 
processes extending out of the body. No changes were seen when the control medium 
was used (Figure 16 C, D) 
Nevertheless, whether if this staining is specific remains to be investigated, as no 












Figure 16. Images of Oil Red-O staining for adipogenic differentiation, Alizarin Red staining for 
osteogenic differentiation and β tubulin III staining for neural differentiation on day 28 cultured 
human dental pulp pericytes and MSCs.  
(A) no evidence of adipogenic differentiation in pericytes or MSCs, (B) evidence of calcium deposits in 
red colour in both cell populations (C) evidence of tubulin III staining, in both cell populations. Cells 
appeared long, flat elongated with processes extending out from the end the cell body. Nuclei illustrated 
in the centre of the cell with a round/oval shape (D) Boxed area in c is showed enlarged. Arrows 








Dental pulp perivascular cells isolation using flow cytometry  
 
Perivascular cells are present in human tissues in different frequencies depending on 
the types of vessels present (Murray and Péault, 2015). Dental pulp is highly 
vascularised and is a great and easy source of mesenchymal stem cells. However, 
the frequency of each type of perivascular cells in the dental pulp is not known. To 
investigate this aspect, we performed eighteen individual experiments with teeth from 
both male (7) and female (11) subjects. 
We enzymatically digested the dental pulp to obtain a single cell suspension and used 
flow cytometry to quantify perivascular cells. Viable cells were selected excluding 
debris, dead cells and doublets (Figure 17 A). CD56+ cells were then gated out of 
dental pulp cell suspensions to avoid contamination due to the overlap with pericyte 
markers. In order to remove endothelial cells and hematopoietic cells we used 
negative selection for CD31 and CD45 (Figure 17 C). In parallel, we derived MSCs in 
culture from total unfractionated samples. 
Moreover, pericytes and adventitial cells were then identified by the expression of 
CD146 and CD34, as CD146+CD34- and CD34+CD146- respectively (Figure 17 A, 
iv). On average, we found that the dental pulp consisted of 10% pericytes 1-2% 










Dental pulp pericyte subsets can be further sorted according to NG2 
expression.  
 
As we illustrated using immunohistochemistry, not all perivascular cells express NG2. 
To test this, we next analysed 18 dental pulp samples by flow cytometry and we 
confirmed that a subset of CD146+CD34-CD31-CD56- pericytes indeed express NG2. 
However, we found that the majority of pericytes in the dental pulp are negative for 
NG2. Indeed, NG2+ pericytes represent around 5.9% of the total dental pulp pericyte 
population and this is significantly lower (p<0.001) than NG2- pericytes (Figure 17 C).  
To further characterise these pericyte subsets and to test their differential potentials in 
vitro, we next sorted these cells based on NG2 expression and established culture cell 











Figure 17. Quantification of the perivascular cell compartment in the dental pulp 
(A) Perivascular cells are sorted as live single cells, negative for CD31, CD45 and CD56. Pericytes are 
CD146+CD34-. Adventitial cells are CD34+CD146-. Pericytes are further divided into 2 subgroups, 
NG2+ and NG2- then sorted. (B) The comparison between pericytes and adventitial cells in the dental 
pulp shows that pericytes are significantly more abundant. Unpaired t-test with Welch’s correction was 
used. Data are shown as mean with SEM, N=18, *p=0.0445. (C) Percentages of NG2+ and NG2- 
pericytes in the dental pulp. Unpaired t-test with Welch’s correction was used. Data are shown as mean 










Determine the developmental potential of dental 
pulp-derived perivascular cell subsets, in vitro 
 
Sorted dental pulp perivascular cells were seeded according to our established 
protocol (Crisan et al, 2008). In short, freshly sorted cells were cultured in endothelial 
cell medium, on gelatin-coated plates. To derive these cell populations a particular cell 
density was needed in order for the cells to be cultured successfully. Cell viability was 
low when less than 1,000 cells were seeded after sorting. So, all our samples that 
have grown in culture had more than 1,000 cells. One week after culture initiation, 
EGM-2 medium was replaced by DMEM supplemented with 20% FBS and 1% 
penicillin-streptomycin (PS).  Recently attached cells exhibited mixed elongated, 
spindle and polygonal shapes. After cells were passaged once, they exhibited star-
like shapes with prominent nuclei and multiple cytoplasmic extensions.  
Ten samples were cultured up to passage 8 for about 2 months. 
Adipogenic, osteogenic and neurogenic potentials of the same sample populations of 
dental pulp adventitial cells, NG2+ pericytes and NG2- pericytes sub-populations, at 
passage six, were evaluated at 7, 14, 21 and 28 days.  
 
Adipogenic differentiation  
Any cells undergoing adipose differentiation change their morphology and form intra-
cytoplasmic lipid droplets. These lipid deposits are stained with Oil red O. The limited 








been reported by Fracaro and team (Fracaro et al., 2020). NG2+ pericytes 
differentiated into adipocytes, as illustrated by Oil Red O staining of lipid droplets into 
the cytoplasm compared to the control where these changes were not observed 
(Figure 18). Indeed, the differentiation started at day 14 and was maintained in both 
day 21 and 28. Interestingly, NG2- pericytes or adventitial cells were not able to 
accumulate lipid droplets at any time points studied (Figure 18).  
 
Figure 18. Adipogenic differentiation of cultured sorted perivascular cells in vitro on day 7, 14, 
21, 28 in adventitial cells, NG2+ and NG2- pericytes from cultured human dental pulp, in control 
medium (first row), and adipogenic medium (second row).  
(A) Day 7: No differentiation detected in any of the three cell groups (B) Day 14: NG2+ pericytes are 
differentiating, black narrows indicate lipid droplets. (C) Day 21: NG2+ pericytes show are differentiating 
(red-brown lipid droplets) whereas NG2- pericytes and adventitial cells do not. (D) Day 28: adipogenic 
differentiation revealed from NG2+ pericyte population with the appearance of red-brown lipid droplets. 









Osteogenic differentiation  
Cells undergoing osteogenic differentiation accumulate calcium deposits that are 
revealed with alizarin red staining. Adventitial cells, NG2- pericytes and NG2+ 
pericytes exposed to osteogenic medium differentiated into calcified mineral matrix-
secreting cells as early as 14 days following the induction of osteogenic differentiation 
(Figure 19). Osteogenic capacity was quantified by extraction of alizarin from the 
calcium deposits with acetic acid and subsequent analysis using spectrophotometry 
(Figure 20). 
 
Figure 19. Osteogenic potential of adventitial cells and NG2+ and NG2- pericytes revealed by 
Alizarin Red staining on day 7, 14, 21 and 28 of cultured human dental pulp cell populations in 
control (first row) and differentiation conditions (second row). 
 (A) Day 7: no osteogenic differentiation (B) Day 14: calcium deposits (red colour) are evident in all 
three groups (black arrow) (C) Day 21 and (D) Day 28: further osteogenic differentiation. Staining 










Subsets of NG2 pericytes and adventitial cells in the dental pulp illustrated 
similar osteogenic potential using quantification for alizarin red staining. 
Osteogenic differentiation of dental pulp perivascular cells has been seen in eight 
independent experiments and it was identified by alizarin red staining and 
spectrophotometry. Further spectrophotometry technology was used to quantify 
osteogenic output of subsets NG2+ and NG2- pericytes, and adventitial cells to identify 
any differences in these three cell groups at 7-, 14-, 21- and 28-days post-induction. 
Firstly, we observed that after 7 days of differentiation there was no osteogenesis in 
either of these three cell populations analysed (Figure 20 A). The osteogenic 
differentiation started at day 14 as shown in figure 20 B. For that time point on, we 
observed statistically significant differences between the undifferentiated control and 
the differentiated cells in all the cell populations (Figure 20 B, C, D).  The osteogenic 
differentiation ability was similar for all the three cell groups as no statistical difference 












Figure 20. Quantification of osteogenic differentiation of cultured adventitial cells, NG2+ and 
NG2- pericytes. 
 (A) 7 days (B) 14 days (C) 21 days (D) 28 days. Unpaired t-test with Welch’s correction was used. 
Data are shown as mean with SEM. N=8, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, ns: not significant. OD: 
Optical density.  
 
Neurogenic differentiation  
Adventitial cells, NG2- and NG2+ pericytes revealed positive response for tubulin β III 
after 28 days when compared to control media when treated with basic fibroblast 
growth factor and epidermal growth factor. Tubulin β III is a neural marker; hence this 








developed to phenotypic neural-like cells following treatment with appropriate growth 
factor in vitro. The staining of tubulin β III might be indicative of neural cell 
differentiation. However, the cell morphology it was not. Neural cells have the following 
characteristics: pyramidal shaped soma and long axonal like extensions. In our 
experiment our cells did not present this morphology. Adventitial cells, NG2- and NG2+ 
pericytes, following the 28-day neural differentiation, appeared large, flat, elongated 
with processes that extending out from the ends of their body. (Figure 21). 
 
Figure 21. Immunofluorescence showing β tubulin III staining for neural differentiation on day 
28 of cultured human dental pulp adventitial cells, NG2+ and NG2-pericytes in control medium 
(first row) and in neural medium (second row). 
Evidence of tubulin β III staining in all cell populations with cells appearing long, flat elongated with an 

































As has been shown, perivascular cells are a highly heterogeneous population of cells. 
Both pericytes and adventitial cells are located in different types of vessels. 
Nevertheless, both cell types are considered an in situ counterpart of mesenchymal 
stem cells (MSCs) (Corselli et al., 2010c, 2012a; Crisan et al., 2008b). In this thesis, 
we investigated the presence of perivascular cells in human dental pulp, their different 
aspects including the location of these cells, and whether dental pulp perivascular cells 
and MSCs are linked.  
Firstly, we have focused on identifying and characterising the dental pulp perivascular 
cells in vivo. Our data show that dental pulp perivascular cells express the classical 
pericyte markers identified in other human organs such as αSMA, CD146, PDGFRβ, 
LepR, CD107a and NG2, but not the endothelial cell markers CD34, Ulex europaeus 
receptor, CD54 and vWF.  The illustration of the above endothelial cell markers on 
dental pulp sections proved the presence of a developed vascular network in the adult 
human tooth. Having a functional vascular network includes the participation and 
interaction of different cell types including endothelial cells, pericytes, macrophages, 
essential for angiogenesis (Hur et al., 2004; Rafii and Lyden, 2003). The data of our 
study are in agreement with previous studies by our group and others pertaining to the 
isolation of pericytes from other tissues (Corselli et al., 2013; Crisan et al., 2012b, 
2008b, 2008a; James et al., 2017; Péault et al., 2007; Shi and Gronthos, 2003b). 
Moreover, we have illustrated that not all pericytes express the same markers and 
localisation of pericytes is one of the reasons for this heterogeneity. Indeed, we have 








arterioles and venules. CD146 and PDGFRβ are expressed in capillaries, arterioles 
and venules, NG2 and LepR are expressed in both capillaries and arterioles but not 
venules. Alliot-Licht and team have utilized total pulp cells and have shown that a 
population of αSMA positive cells can form mineralised nodules in vitro, suggesting 
that the bone/dentin progenitors are perivascular cells (Alliot-Licht et al., 2001; Shi and 
Gronthos, 2003b) . The expression of leptin in the dental pulp  has been shown before 
(J. Martín-González et al., 2013) but it was not illustrated which cells expressed LepR.  
It was important to identify if all pericytes express LepR especially as shown to be 
essential for alveolar bone regeneration (Zhang et al., 2020). Our work found that 
LepR was not always expressed in pericytes in capillaries (Figure 10).  Leptin is the 
ligand of LepR, a hormone which derives from adipocytes, and was initially associated 
with lipid metabolism and obesity (Coleman, 1978). LepR/Leptin signaling has been 
identified to be part of the immune homeostasis, angiogenesis, haematopoiesis, 
reproduction, bone formation, haematological malignancies  and as a possible 
regulator for inflammation associated with dental infections (Chen and Yang, 2015; 
Konopleva et al., 1999; Jénifer Martín-González et al., 2013). Also, cells expressing 
LepR have been shown to be essential for alveolar bone regeneration (Zhang et al., 
2020).  
Giulio Cossu (Dellavalle et al., 2007) used ALP to isolate pericytes from human 
skeletal muscle for example, and we confirmed that ALP is also a pericyte marker of 
cultured pericytes in other organs (Crisan et al., 2008b). Interestingly, we found that 
dental pulp perivascular cells also express ALP. To summarize, we have identified the 
molecular signature of pericytes in dental pulp as described:  CD146+ a-SMA+/- 








Secondly, using immunohistochemistry, we also found that dental pulp perivascular 
cells express CD29, CD90 and CD44, MSC markers. Numerous studies have been 
carried out from our group, and others too, demonstrating that in other organs 
perivascular cells are the in vitro counterpart of the MSCs. Initially it was assumed  that 
all pericytes are MSCs (Caplan, 2008).However,  later it was shown that MSCs arise 
from perivascular cells as well as the fact that MSCs come from various locations, 
such as pericyte and adventitial layers. Perivascular cells  have been characterised as 
an ubiquitous “niche” regenerative cell population with exceptional developmental 
plasticity (Alakpa et al., 2016b; Corselli et al., 2012b, 2010b; Crisan et al., 2008b).  
Furthermore, we have investigated the co-expression of neuronal markers (CD56 and 
vimentin) with pericyte markers (LepR, NG2, CD146) and interestingly we also showed 
here that some neural cells are expressing pericyte markers such as αSMA, NG2, 
CD146, LepR, but not always (Figure 14). The neurogenic ability of pericytes was 
stated and investigated by Geranmayeh and team who reviewed the different subsets 
of pericytes and their neurovascular ability (Geranmayeh et al., 2019). The higher the 
pericyte density is in the CNS, the more likely is for the brain potency to develop a 
blood brain barrier integrity. Two different subtypes of pericytes in muscular tissues 
have been shown by Birbrair and team: the pericyte group which had the ability  to 
transdifferentiate towards adipogenic and fibrogenic lineages (Birbrair et al., 2013) and 
the second pericyte type which possessed the ability towards neurogenic, angiogenic 
and myogenic differentiation (Birbrair et al., 2014) 
 
Following immunohistochemistry results, we identified dental pulp perivascular cells, 








culture. We demonstrated successful isolation of dental pulp-derived perivascular 
cells, namely pericytes and adventitial cells which were consistent between 
experiments. More precisely, we have illustrated the existence of adventitial cells 
(CD34+ CD146- CD31-CD56-) which consist of around 1-2% and pericytes 
(CD146+CD34-CD31-CD56-) of approximately 10-15% of the sorted dental pulp 
perivascular cells. Carlile and team have shown a higher number of perivascular cells 
in the dental pulp (Carlile et al., 2000). In their study, they obtained dental pulp from 
eight wisdom teeth from patients age 17 to 25 years and they found that the dental 
pulp which was rich in capillaries composed of both endothelial and peri-endothelial 
(pericytes, transitional cells and fibroblasts) cells in a 1 to 4 ratio. (Carlile et al., 2000). 
It has been demonstrated that cultured DPSCs contain a population expressing the 
pericyte marker NG2 (Delle Monache et al., 2019). In line with this, we have illustrated 
that a subset of pericytes indeed express NG2 both on section and by flow cytometry. 
However, we found that NG2 is also expressed in neural cells raising the question 
about the origin of NG2+ cells in DPSCs. The importance of NG2 in proteoglycan 
molecular interactions and biological functions has been illustrated before (Girolamo 
et al., 2019). We have seen that all dental pulp perivascular cells are highly 
proliferative and multipotent, same as it was also demonstrated for perivascular cells 
derived from other human tissues (Alakpa et al., 2016; Corselli et al., 2012b, 2010b; 
Crisan et al., 2008b). Furthermore, Q-PRC, quantitative polymerase chain reaction, 
studies for the validation of the immunostainings that performed in this study could be 
done in the future.  
 
Our next step was to investigate the in vitro adipogenic, osteogenic and neurogenic 








literature and the limited ability of DPSCs towards adipogenesis has been reported 
before (Fracaro et al., 2020; Gronthos et al., 2000a; Isobe et al., 2016; 
Monterubbianesi et al., 2019; Tamaki et al., 2013). In our study we found that the 
NG2+ pericyte population was able to differentiate into adipocytes although the 
frequency seemed low. On the other hand, NG2- pericytes, pericytes, adventitial cells 
and MSCs were not adipogenic. These data suggest that the NG2+ pericytes or at 
least a few of them are endowed with a higher adipogenic ability compared to the NG2- 
counterpart that may be "blocked" by the latter when all pericytes are cultured together. 
 
The quantitative osteogenic ability of all five different cell groups we tested here had 
been shown to be similar. In addition, no delay was observed. The calcium deposition 
was found at day 14 post-induction, in all cell lines tested. 
 
Moreover, the in vitro neurogenic ability of all five different cell groups 28 days post-
induction was also revealed in our study with the use of tubulin β III staining. However, 
cell morphology was not indicative of neural cell differentiation. Tubulin β III has been 
used before in order to identify neuron-like cells (Isobe et al., 2016; Tamaki et al., 
2013). Several other studies have shown that hDPSCs have the ability to differentiate 
into neuronal-like cells or dopaminergic neuron-like cells (Ullah et al., 2016; Young et 
al., 2016). Pisciotta and team compared two subpopulations of hDPSCs based on 
CD34 expression and demonstrated different properties on the expression of neural 
markers (Pisciotta et al., 2015). They isolated two populations of hDPSCs based on 
STRO-1 and c-Kit expression associated or not to CD34. Pisciotta and team found 
that these two hDPSCs populations (STRO-1+/ c-Kit+/CD34- and STRO-1+/c-








stemness maintenance and cell senescence/ apoptosis upon late passages. Moreover 
the CD34+ population demonstrated in vitro a stronger tendency after 3 weeks towards 
the neurogenic differentiation; whereas the differentiation ability of both hDPSCs 
populations towards mesoderm linages was similar.(Pisciotta et al., 2015)  
In our study cell morphology was not indicative to neural cells though the staining of 
tubulin β III might suggest that longer exposure in culture was required. Nevertheless, 
in our experiments we did not have a negative control for tubulin β ΙΙΙ. Thus, if this 
staining is specific remains to be investigated. This can be clarified in the future, in 
several ways such as by adding a negative control of the staining, or by doing the 
same staining on neural cells using them as positive control (for example brain cells), 
or by using the tubulin β III staining on epithelial cells and other unrelated cells that 
would have another negative control. 
 Furthermore, tubulin β III was the only neural markers we used, in contrast with 
Pisciotta and team who used tubulin β III as well as MAP 2, NEU-N synapsin, a glial 
specific marker (GFAP) and anti-Notch 3 ,Neurogenic locus notch homolog protein 3), 
antibody (Pisciotta et al., 2015). 
 
There is an extensive need to develop safe and effective methods to regenerate soft 
and hard tissues for craniofacial diseases such as head and neck cancers, trauma, 
birth defects/ orofacial cleft, periodontal disease and pulp injuries. Cellular approaches 
provide an attractive option to develop therapies targeted for the craniofacial 
regeneration. Engineering cellular therapies for craniofacial regeneration requires the 









With the above approach we set the step for a well-characterised dental pulp 
perivascular stem cell population of high purity that can be expanded and differentiate. 
Dental pulp-derived perivascular cells should therefore be amenable to study and 
develop targeted dental therapies as well as nerve and bone regeneration strategies.   
Interestingly, this project shows that pericytes and adventitial cells in culture are 
not functional MSCs in vitro, but rather bone progenitors (at least in our 
conditions).  They express MSC markers in situ, they are adherent to plastic dishes, 
they have MSC morphology, but they are not multipotent in vitro. However, they are 
highly osteogenic and on sections they share markers with pericytes.  
 
Specifically, dental cell therapies have recently garnered a lot of attention. Dentin, 
dental pulp, and cementum-periodontal complex regeneration has been shown with 
DPSCs, stem cells from human exfoliated deciduous teeth (SHEDs) and periodontal 
ligament stem cells (Shi et al., 2020). Root-periodontal complex regeneration has been 
shown with cells from apical papilla and periodontal ligament (Y.-J. Chen et al., 2015). 
Hard tissue formation with rat dental pulp cells has also been shown in vivo (Yang et 
al., 2009). FACS isolated dental pulp perivascular cells, namely pericytes and 
adventitial cells are promising a unique cell source to assess the in vivo differentiation 
potential of these cells into dental tissues. Due to the availability of deciduous teeth 
and third molar teeth, dental pulp perivascular cells can provide a convenient source 
of therapeutic cells to regenerate dental tissues as well as tissues of other mesodermal 
lineages such as bone, nerve and fat. Nevertheless, current data does not support yet 
a neuronal differentiation as more markers should be tested such as MAP2 and a glial 








Our experiments for neurogenic differentiation followed the protocol by  Arthur and 
team (Arthur et al., 2008). Although we both used adult human teeth, and same media 
and conditions, Arthur and team used other supplementary staining: nestin, polysialic 
acid-neural cell adhesion molecule (PSA-NCAM), neurofilament-medium chain (NF-
M), mature neuronal marker neurofilament-heavy chain (NF-H) and differentiation took 
place for 3 weeks instead of 28 days. They also found an increase in β tubulin III cell 
expression following the induction of the neuronal medium (Arthur et al., 2008). The 
reason we choose to use the β tubulin III is that this molecule is the only 
phosphorylated tubulin. It is considered to be a neuronal-specific marker that is 
expressed at early brain development and is down-regulated as the brain develops 
into adulthood (Jiang and Oblinger, 1992) 
 
Future research  
 
This research project provides an important base on which further studies could build 
on. It was mentioned before that using the FACS analysis at an early passage is vital 
for future research on dental pulp derived cells as guarantee for a pure stem cell. 
Further questions to be addressed: 
1. What is the difference between dental pulp adventitial cells and pericytes, and 
which one is better in bone regeneration? Wang and team illustrated that adipose-
derived CD146+ pericytes and CD34+ adventitial cells display functionally distinct 
yet overlapping and complementary roles in bone defect repair (Wang et al., 2019). 








inject them in mouse models where bone/tooth was injured? Could dental pulp be 
used as a source for regeneration of other types of bone such as long bone? 
2. Are dental pulp pericytes and adventitial cells developmentally linked? Is one giving 
rise to another and vice versa?  
3.  Will it be possible to sort and culture CD56+ cells in vitro and differentiate into 
neurons or into pericytes? Are they MSCs as well? 
4. Will be possible to Replace the missing dental pulp tissue, endodontics? 
 
Stem cell treatment is a fascinating dynamic aspect of medical research and using 
perivascular cells in an accurate way might lead to an important foundation for further 













































About, I., Laurent-Maquin, D., Lendahl, U., Mitsiadis, T.A., 2000. Nestin expression in embryonic and 
adult human teeth under normal and pathological conditions. Am. J. Pathol. 157, 287–295. 
https://doi.org/10.1016/S0002-9440(10)64539-7 
Alakpa, E.V., Jayawarna, V., Lampel, A., Burgess, K.V., West, C.C., Bakker, S.C.J., Roy, S., Javid, N., 
Fleming, S., Lamprou, D.A., Yang, J., Miller, A., Urquhart, A.J., Frederix, P.W.J.M., Hunt, N.T., 
Péault, B., Ulijn, R.V., Dalby, M.J., 2016a. Tunable Supramolecular Hydrogels for Selection of 
Lineage-Guiding Metabolites in Stem Cell Cultures. Chem 1, 298–319. 
https://doi.org/10.1016/j.chempr.2016.07.001 
Alakpa, E.V., Jayawarna, V., Lampel, A., Burgess, K.V., West, C.C., Bakker, S.C.J., Roy, S., Javid, N., 
Fleming, S., Lamprou, D.A., Yang, J., Miller, A., Urquhart, A.J., Frederix, P.W.J.M., Hunt, N.T., 
Péault, B., Ulijn, R.V., Dalby, M.J., 2016b. Tunable Supramolecular Hydrogels for Selection of 
Lineage-Guiding Metabolites in Stem Cell Cultures. Chem 1, 298–319. 
https://doi.org/10.1016/j.chempr.2016.07.001 
Alakpa, E. V, Jayawarna, V., Burgess, K.E. V, West, C.C., Péault, B., Ulijn, R. V, Dalby, M.J., 2017. 
Improving cartilage phenotype from differentiated pericytes in tunable peptide hydrogels. Sci. 
Rep. 7, 6895. https://doi.org/10.1038/s41598-017-07255-z 
Alaminos, M., Sanchez-Quevedo, M.C., Muñoz-Ávila, J.I., García, J.M., Crespo, P.V., González-
Andrades, M., Campos, A., 2007. Evaluation of the viability of cultured corneal endothelial cells 
by quantitative electron probe X-ray microanalysis. J. Cell. Physiol. 211, 692–698. 
https://doi.org/10.1002/jcp.20976 
Alliot-Licht, B., Hurtrel, D., Gregoire, M., 2001. Characterization of a-smooth muscle actin positive cells 
in mineralized human dental pulp cultures 8. 
Amado, L.C., Saliaris, A.P., Schuleri, K.H., St. John, M., Xie, J.-S., Cattaneo, S., Durand, D.J., Fitton, 
T., Kuang, J.Q., Stewart, G., Lehrke, S., Baumgartner, W.W., Martin, B.J., Heldman, A.W., 
Hare, J.M., 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem 
cells after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 102, 11474 LP – 11479. 
https://doi.org/10.1073/pnas.0504388102 
Armulik, A., Genové, G., Betsholtz, C., 2011. Pericytes: Developmental, Physiological, and Pathological 
Perspectives, Problems, and Promises. Dev. Cell 21, 193–215. 
https://doi.org/10.1016/j.devcel.2011.07.001 
Arthur, A., Rychkov, G., Shi, S., Koblar, S.A., Gronthos, S., 2008. Adult human dental pulp stem cells 
differentiate toward functionally active neurons under appropriate environmental cues. Stem 
Cells Dayt. Ohio 26, 1787–1795. https://doi.org/10.1634/stemcells.2007-0979 
Arthur, A., Shi, S., Zannettino, A.C.W., Fujii, N., Gronthos, S., Koblar, S.A., 2009. Implanted adult 
human dental pulp stem cells induce endogenous axon guidance. Stem Cells Dayt. Ohio 27, 
2229–2237. https://doi.org/10.1002/stem.138 
Attwell, D., Mishra, A., Hall, C.N., O’Farrell, F.M., Dalkara, T., 2015. What is a pericyte? J. Cereb. Blood 
Flow Metab. 36, 451–455. https://doi.org/10.1177/0271678X15610340 
AU  - Vezzani, B., AU  - Gomez-Salazar, M., AU  - Casamitjana, J., AU  - Tremolada, C., AU  - Péault, 
B., 2019. Human Adipose Tissue Micro-fragmentation for Cell Phenotyping and Secretome 
Characterization. J. Vis. Exp. e60117. https://doi.org/doi:10.3791/60117 
Augello, A., Tasso, R., Negrini, S.M., Amateis, A., Indiveri, F., Cancedda, R., Pennesi, G., 2005. Bone 
marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the 
programmed death 1 pathway. Eur. J. Immunol. 35, 1482–1490. 
https://doi.org/10.1002/eji.200425405 
Awais, S., Balouch, S.S., Riaz, N., Choudhery, M.S., 2020. Human Dental Pulp Stem Cells Exhibit 
Osteogenic Differentiation Potential. Open Life Sci. 15, 229–236. https://doi.org/10.1515/biol-
2020-0023 
Balic, A., Aguila, H.L., Caimano, M.J., Francone, V.P., Mina, M., 2010. Characterization of stem and 









Barry, F., Boynton, R., Murphy, M., Zaia, J., 2001. The SH-3 and SH-4 Antibodies Recognize Distinct 
Epitopes on CD73 from Human Mesenchymal Stem Cells. Biochem. Biophys. Res. Commun. 
289, 519–524. https://doi.org/10.1006/bbrc.2001.6013 
Barry, F.P., Boynton, R.E., Haynesworth, S., Murphy, J.M., Zaia, J., 1999. The Monoclonal Antibody 
SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin 
(CD105). Biochem. Biophys. Res. Commun. 265, 134–139. 
https://doi.org/10.1006/bbrc.1999.1620 
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., 
Banovic, M., Beleslin, B., Vrolix, M., Legrand, V., Vrints, C., Vanoverschelde, J.L., Crespo-Diaz, 
R., Homsy, C., Tendera, M., Waldman, S., Wijns, W., Terzic, A., 2013. Cardiopoietic Stem Cell 
Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) 
Multicenter Randomized Trial With Lineage-Specified Biologics. J. Am. Coll. Cardiol. 61, 2329–
2338. https://doi.org/10.1016/j.jacc.2013.02.071 
Bartunek, J., Davison, B., Sherman, W., Povsic, T., Henry, T.D., Gersh, B., Metra, M., Filippatos, G., 
Hajjar, R., Behfar, A., Homsy, C., Cotter, G., Wijns, W., Tendera, M., Terzic, A., 2016. 
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design. Eur. J. 
Heart Fail. 18, 160–168. https://doi.org/10.1002/ejhf.434 
Basciano, L., Nemos, C., Foliguet, B., de Isla, N., de Carvalho, M., Tran, N., Dalloul, A., 2011. Long 
term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining 
their undifferentiated and multipotent status. BMC Cell Biol. 12, 12. 
https://doi.org/10.1186/1471-2121-12-12 
Birbrair, A., Zhang, T., Wang, Z.-M., Messi, M.L., Mintz, A., Delbono, O., 2013. Type-1 pericytes 
participate in fibrous tissue deposition in aged skeletal muscle. Am. J. Physiol.-Cell Physiol. 
305, C1098–C1113. https://doi.org/10.1152/ajpcell.00171.2013 
Birbrair, A., Zhang, T., Wang, Z.-M., Messi, M.L., Olson, J.D., Mintz, A., Delbono, O., 2014. Type-2 
pericytes participate in normal and tumoral angiogenesis. Am. J. Physiol.-Cell Physiol. 307, 
C25–C38. https://doi.org/10.1152/ajpcell.00084.2014 
Bonner, J.C., 2004. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor 
Rev. 15, 255–273. https://doi.org/10.1016/j.cytogfr.2004.03.006 
Buchaille, R., Couble, M.L., Magloire, H., Bleicher, F., 2000. Expression of the small leucine-rich 
proteoglycan osteoadherin/osteomodulin in human dental pulp and developing rat teeth. Bone 
27, 265–270. https://doi.org/10.1016/s8756-3282(00)00310-0 
Caliari, S.R., Vega, S.L., Kwon, M., Soulas, E.M., Burdick, J.A., 2016. Dimensionality and spreading 
influence MSC YAP/TAZ signaling in hydrogel environments. Biomaterials 103, 314–323. 
https://doi.org/10.1016/j.biomaterials.2016.06.061 
Caplan, A.I., 2008. All MSCs are pericytes? Cell Stem Cell 3, 229–230. 
https://doi.org/10.1016/j.stem.2008.08.008 
Caplan, A.I., 1991. Mesenchymal stem cells. J. Orthop. Res. 9, 641–650. 
https://doi.org/10.1002/jor.1100090504 
Carlile, M.J., Sturrock, M.G., Chisholm, D.M., Ogden, G.R., Schor, A.M., 2000. [No title found]. 
Histochem. J. 32, 239–245. https://doi.org/10.1023/A:1004055118334 
Chamberlain, G., Fox, J., Ashton, B., Middleton, J., 2007. Concise review: mesenchymal stem cells: 
their phenotype, differentiation capacity, immunological features, and potential for homing. 
Stem Cells Dayt. Ohio 25, 2739–49. https://doi.org/10.1634/stemcells.2007-0197 
Chen, W.C.W., Péault, B., Huard, J., 2015. Regenerative Translation of Human Blood-Vessel-Derived 
MSC Precursors. Stem Cells Int. 2015, 375187. https://doi.org/10.1155/2015/375187 
Chen, X.X., Yang, T., 2015. Roles of leptin in bone metabolism and bone diseases. J. Bone Miner. 
Metab. 33, 474–485. https://doi.org/10.1007/s00774-014-0569-7 
Chen, Y.-J., Zhao, Y.-H., Zhao, Y.-J., Liu, N.-X., Lv, X., Li, Q., Chen, F.-M., Zhang, M., 2015. Potential 
dental pulp revascularization and odonto-/osteogenic capacity of a novel transplant combined 
with dental pulp stem cells and platelet-rich fibrin. Cell Tissue Res. 361, 439–455. 
https://doi.org/10.1007/s00441-015-2125-8 
Coleman, D.L., 1978. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in 
mice. Diabetologia 14, 141–148. https://doi.org/10.1007/BF00429772 
Corselli, M., Chen, C.W., Crisan, M., Lazzari, L., Péault, B., 2010a. Perivascular ancestors of adult 









Corselli, M., Chen, C.-W., Crisan, M., Lazzari, L., Péault, B., 2010b. Perivascular ancestors of adult 
multipotent stem cells. Arterioscler. Thromb. Vasc. Biol. 30, 1104–1109. 
https://doi.org/10.1161/ATVBAHA.109.191643 
Corselli, M., Chen, C.W., Crisan, M., Lazzari, L., Péault, B., 2010c. Perivascular ancestors of adult 
multipotent stem cells. Arterioscler. Thromb. Vasc. Biol. 30, 1104–1109. 
https://doi.org/10.1161/ATVBAHA.109.191643 
Corselli, M., Chen, C.-W., Sun, B., Yap, S., Rubin, J.P., Péault, B., 2012a. The tunica adventitia of 
human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 21, 1299–
308. https://doi.org/10.1089/scd.2011.0200 
Corselli, M., Chen, C.-W., Sun, B., Yap, S., Rubin, J.P., Péault, B., 2012b. The tunica adventitia of 
human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 21, 1299–
1308. https://doi.org/10.1089/scd.2011.0200 
Corselli, M., Chin, C.J., Parekh, C., Sahaghian, A., Wang, W., Ge, S., Evseenko, D., Wang, X., 
Montelatici, E., Lazzari, L., Crooks, G.M., Péault, B., 2013. Perivascular support of human 
hematopoietic stem/progenitor cells. Blood 121, 2891–2901. https://doi.org/10.1182/blood-
2012-08-451864 
Covas, D.T., Panepucci, R.A., Fontes, A.M., Silva, W.A., Orellana, M.D., Freitas, M.C.C., Neder, L., 
Santos, A.R.D., Peres, L.C., Jamur, M.C., Zago, M.A., 2008. Multipotent mesenchymal stromal 
cells obtained from diverse human tissues share functional properties and gene-expression 
profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36, 642–654. 
https://doi.org/10.1016/j.exphem.2007.12.015 
Crisan, M., Casteilla, L., Lehr, L., Carmona, M., Paoloni-Giacobino, A., Yap, S., Sun, B., Léger, B., 
Logar, A., Pénicaud, L., Schrauwen, P., Cameron-Smith, D., Russell, A.P., Péault, B., 
Giacobino, J.-P., 2008a. A Reservoir of Brown Adipocyte Progenitors in Human Skeletal 
Muscle. Stem Cells 26, 2425–2433. https://doi.org/10.1634/stemcells.2008-0325 
Crisan, M., Chen, C.-W., Corselli, M., Andriolo, G., Lazzari, L., Péault, B., 2009. Perivascular Multipotent 
Progenitor Cells in Human Organs. Ann. N. Y. Acad. Sci. 1176, 118–123. 
https://doi.org/10.1111/j.1749-6632.2009.04967.x 
Crisan, M., Corselli, M., Chen, W.C.W., Péault, B., 2012a. Perivascular cells for regenerative medicine. 
J. Cell. Mol. Med. 16, 2851–2860. https://doi.org/10.1111/j.1582-4934.2012.01617.x 
Crisan, M., Corselli, M., Chen, W.C.W., Péault, B., 2012b. Perivascular cells for regenerative medicine. 
J. Cell. Mol. Med. 16, 2851–2860. https://doi.org/10.1111/j.1582-4934.2012.01617.x 
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., 
Zhang, L., Norotte, C., Teng, P.-N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Bűhring, 
H.-J., Giacobino, J.-P., Lazzari, L., Huard, J., Péault, B., 2008b. A Perivascular Origin for 
Mesenchymal Stem Cells in Multiple Human Organs. Cell Stem Cell 3, 301–313. 
https://doi.org/10.1016/J.STEM.2008.07.003 
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., 
Zhang, L., Norotte, C., Teng, P.-N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Bűhring, 
H.-J., Giacobino, J.-P., Lazzari, L., Huard, J., Péault, B., 2008c. A Perivascular Origin for 
Mesenchymal Stem Cells in Multiple Human Organs. Cell Stem Cell 3, 301–313. 
https://doi.org/10.1016/j.stem.2008.07.003 
d’Aquino, R., De Rosa, A., Laino, G., Caruso, F., Guida, L., Rullo, R., Checchi, V., Laino, L., Tirino, V., 
Papaccio, G., 2009a. Human dental pulp stem cells: from biology to clinical applications. J. Exp. 
Zoolog. B Mol. Dev. Evol. 312B, 408–415. https://doi.org/10.1002/jez.b.21263 
d’Aquino, R., De Rosa, A., Laino, G., Caruso, F., Guida, L., Rullo, R., Checchi, V., Laino, L., Tirino, V., 
Papaccio, G., 2009b. Human dental pulp stem cells: from biology to clinical applications. J. Exp. 
Zoolog. B Mol. Dev. Evol. 312B, 408–415. https://doi.org/10.1002/jez.b.21263 
d’Aquino, R., Papaccio, G., Laino, G., Graziano, A., 2008. Dental Pulp Stem Cells: A Promising Tool 
for Bone Regeneration. Stem Cell Rev. 4, 21–26. https://doi.org/10.1007/s12015-008-9013-5 
da Silva Meirelles, L., Sand, T.T., Harman, R.J., Lennon, D.P., Caplan, A.I., 2008. MSC Frequency 
Correlates with Blood Vessel Density in Equine Adipose Tissue. Tissue Eng. Part A 15, 221–
229. https://doi.org/10.1089/ten.tea.2008.0103 
Dellavalle, A., Maroli, G., Covarello, D., Azzoni, E., Innocenzi, A., Perani, L., Antonini, S., Sambasivan, 
R., Brunelli, S., Tajbakhsh, S., Cossu, G., 2011. Pericytes resident in postnatal skeletal muscle 









Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., Innocenzi, A., 
Galvez, B.G., Messina, G., Morosetti, R., Li, S., Belicchi, M., Peretti, G., Chamberlain, J.S., 
Wright, W.E., Torrente, Y., Ferrari, S., Bianco, P., Cossu, G., 2007. Pericytes of human skeletal 
muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255–267. 
https://doi.org/10.1038/ncb1542 
Delle Monache, S., Martellucci, S., Clementi, L., Pulcini, F., Santilli, F., Mei, C., Piccoli, L., Angelucci, 
A., Mattei, V., 2019. In Vitro Conditioning Determines the Capacity of Dental Pulp Stem Cells 
to Function as Pericyte-Like Cells. Stem Cells Dev. 28, 695–706. 
https://doi.org/10.1089/scd.2018.0192 
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Krause, D.S., Deans, R.J., 
Keating, A., Prockop, D.J., Horwitz, E.M., 2006. Minimal criteria for defining multipotent 
mesenchymal stromal cells. The International Society for Cellular Therapy position statement. 
Cytotherapy 8, 315–317. https://doi.org/10.1080/14653240600855905 
Dzhoyashvili, N.A., Efimenko, A.Y., Kochegura, T.N., Kalinina, N.I., Koptelova, N.V., Sukhareva, O.Y., 
Shestakova, M.V., Akchurin, R.S., Tkachuk, V.A., Parfyonova, Y.V., 2014. Disturbed 
angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery 
disease and diabetes mellitus type 2. J. Transl. Med. 12, 337. https://doi.org/10.1186/s12967-
014-0337-4 
Elsharkawy, S., Al-Jawad, M., Pantano, M.F., Tejeda-Montes, E., Mehta, K., Jamal, H., Agarwal, S., 
Shuturminska, K., Rice, A., Tarakina, N.V., Wilson, R.M., Bushby, A.J., Alonso, M., Rodriguez-
Cabello, J.C., Barbieri, E., del Río Hernández, A., Stevens, M.M., Pugno, N.M., Anderson, P., 
Mata, A., 2018. Protein disorder–order interplay to guide the growth of hierarchical mineralized 
structures. Nat. Commun. 9, 2145. https://doi.org/10.1038/s41467-018-04319-0 
Erices, A., Conget, P., Minguell, J.J., 2000. Mesenchymal progenitor cells in human umbilical cord 
blood. Br. J. Haematol. 109, 235–242. https://doi.org/10.1046/j.1365-2141.2000.01986.x 
Eskelinen, E.-L., Tanaka, Y., Saftig, P., 2003. At the acidic edge: emerging functions for lysosomal 
membrane proteins. Trends Cell Biol. 13, 137–145. https://doi.org/10.1016/S0962-
8924(03)00005-9 
Fan, L., Hu, C., Chen, J., Cen, P., Wang, J., Li, L., 2016. Interaction between Mesenchymal Stem Cells 
and B-Cells. Int. J. Mol. Sci. https://doi.org/10.3390/ijms17050650 
Fatehullah, A., Tan, S.H., Barker, N., 2016. Organoids as an in vitro model of human development and 
disease. Nat. Cell Biol. 18, 246. 
Feng, J., Mantesso, A., De Bari, C., Nishiyama, A., Sharpe, P.T., 2011. Dual origin of mesenchymal 
stem cells contributing to organ growth and repair. Proc. Natl. Acad. Sci. 108, 6503–6508. 
https://doi.org/10.1073/pnas.1015449108 
Ferrini, M.G., Vernet, D., Magee, T.R., Shahed, A., Qian, A., Rajfer, J., Gonzalez-Cadavid, N.F., 2002. 
Antifibrotic Role of Inducible Nitric Oxide Synthase. Nitric Oxide 6, 283–294. 
https://doi.org/10.1006/niox.2001.0421 
Fields, R.D., Itoh, K., 1996. Neural cell adhesion molecules in activity-dependent development and 
synaptic plasticity. Trends Neurosci. 19, 473–480. https://doi.org/10.1016/S0166-
2236(96)30013-1 
Fracaro, L., Senegaglia, A.C., Herai, R.H., Leitolis, A., Boldrini-Leite, L.M., Rebelatto, C.L.K., Travers, 
P.J., Brofman, P.R.S., Correa, A., 2020. The Expression Profile of Dental Pulp-Derived Stromal 
Cells Supports Their Limited Capacity to Differentiate into Adipogenic Cells. Int. J. Mol. Sci. 21, 
2753. https://doi.org/10.3390/ijms21082753 
Friedenstein, A.J., 1976. Precursor Cells of Mechanocytes, in: International Review of Cytology. 
Elsevier, pp. 327–359. https://doi.org/10.1016/S0074-7696(08)60092-3 
Friedenstein, A.J., Chailakhyan, R.K., Gerasimov, U. V, 1987. Bone marrow osteogenic stem cells: in 
vitro cultivation and transplantation in diffusion chambers. Cell Prolif. 20, 263–272. 
https://doi.org/10.1111/j.1365-2184.1987.tb01309.x 
Friedenstein, A.J., Deriglasova, U.F., Kulagina, N.N., Panasuk, A.F., Rudakowa, S.F., Luriá, E.A., 
Ruadkow, I.A., 1974. Precursors for fibroblasts in different populations of hematopoietic cells 
as detected by the in vitro colony assay method. Exp. Hematol. 2, 83—92. 
Friedenstein, A.J., Piatetzky-Shapiro, I.I., Petrakova, K. V, 1966. Osteogenesis in transplants of bone 
marrow cells. J. Embryol. Exp. Morphol. 16, 381 LP – 390. 
Galleu, A., Riffo-Vasquez, Y., Trento, C., Lomas, C., Dolcetti, L., Cheung, T.S., von Bonin, M., Barbieri, 
L., Halai, K., Ward, S., Weng, L., Chakraverty, R., Lombardi, G., Watt, F.M., Orchard, K., Marks, 








mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci. Transl. 
Med. 9, eaam7828. https://doi.org/10.1126/scitranslmed.aam7828 
Gandia, C., Armiñan, A., García-Verdugo, J.M., Lledó, E., Ruiz, A., Miñana, M.D., Sanchez-Torrijos, J., 
Payá, R., Mirabet, V., Carbonell-Uberos, F., Llop, M., Montero, J.A., Sepúlveda, P., 2008a. 
Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and 
reduce infarct size in rats with acute myocardial infarction. Stem Cells Dayt. Ohio 26, 638–645. 
https://doi.org/10.1634/stemcells.2007-0484 
Gandia, C., Armiñan, A., García-Verdugo, J.M., Lledó, E., Ruiz, A., Miñana, M.D., Sanchez-Torrijos, J., 
Payá, R., Mirabet, V., Carbonell-Uberos, F., Llop, M., Montero, J.A., Sepúlveda, P., 2008b. 
Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and 
reduce infarct size in rats with acute myocardial infarction. Stem Cells Dayt. Ohio 26, 638–645. 
https://doi.org/10.1634/stemcells.2007-0484 
Gao, F., Chiu, S.M., Motan, D.A.L., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., Lian, Q., 2016. 
Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell 
Death Dis. 7, e2062–e2062. https://doi.org/10.1038/cddis.2015.327 
Geranmayeh, M.H., Rahbarghazi, R., Farhoudi, M., 2019. Targeting pericytes for neurovascular 
regeneration. Cell Commun. Signal. 17, 26. https://doi.org/10.1186/s12964-019-0340-8 
Gholamrezanezhad, A., Mirpour, S., Bagheri, M., Mohamadnejad, M., Alimoghaddam, K., 
Abdolahzadeh, L., Saghari, M., Malekzadeh, R., 2011. In vivo tracking of 111In-oxine labeled 
mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl. Med. Biol. 
38, 961–967. https://doi.org/10.1016/j.nucmedbio.2011.03.008 
Gilbert, P.M., Havenstrite, K.L., Magnusson, K.E.G., Sacco, A., Leonardi, N.A., Kraft, P., Nguyen, N.K., 
Thrun, S., Lutolf, M.P., Blau, H.M., 2010. Substrate Elasticity Regulates Skeletal Muscle Stem 
Cell Self-Renewal in Culture. Science 329, 1078 LP – 1081. 
https://doi.org/10.1126/science.1191035 
Giordano, G., La Monaca, G., Annibali, S., Cicconetti, A., Ottolenghi, L., 2011. Stem cells from oral 
niches: a review. Ann. Stomatol. (Roma) 2, 3–8. 
Girolamo, F., Errede, M., Longo, G., Annese, T., Alias, C., Ferrara, G., Morando, S., Trojano, M., Kerlero 
de Rosbo, N., Uccelli, A., Virgintino, D., 2019. Defining the role of NG2-expressing cells in 
experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in 
wild type and NG2 null mice. PLOS ONE 14, e0213508. 
https://doi.org/10.1371/journal.pone.0213508 
Gomes, J.A.P., Geraldes Monteiro, B., Melo, G.B., Smith, R.L., Cavenaghi Pereira da Silva, M., Lizier, 
N.F., Kerkis, A., Cerruti, H., Kerkis, I., 2010. Corneal reconstruction with tissue-engineered cell 
sheets composed of human immature dental pulp stem cells. Invest. Ophthalmol. Vis. Sci. 51, 
1408–1414. https://doi.org/10.1167/iovs.09-4029 
Gomez-Salazar, M., Gonzalez-Galofre, Z.N., Casamitjana, J., Crisan, M., James, A.W., Péault, B., 
2020. Five Decades Later, Are Mesenchymal Stem Cells Still Relevant? Front. Bioeng. 
Biotechnol. 8, 148. https://doi.org/10.3389/fbioe.2020.00148 
Graziano, A., d’Aquino, R., Laino, G., Papaccio, G., 2008. Dental pulp stem cells: a promising tool for 
bone regeneration. Stem Cell Rev. 4, 21–26. https://doi.org/10.1007/s12015-008-9013-5 
Gronthos, S., Brahim, J., Li, W., Fisher, L.W., Cherman, N., Boyde, A., DenBesten, P., Robey, P.G., 
Shi, S., 2002. Stem cell properties of human dental pulp stem cells. J. Dent. Res. 81, 531–535. 
https://doi.org/10.1177/154405910208100806 
Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., Shi, S., 2000a. Postnatal human dental pulp stem 
cells (DPSCs) in vitro and invivo. Proc. Natl. Acad. Sci. 97, 13625–13630. 
https://doi.org/10.1073/pnas.240309797 
Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., Shi, S., 2000b. Postnatal human dental pulp stem 
cells (DPSCs) in vitro and invivo. Proc. Natl. Acad. Sci. 97, 13625–13630. 
https://doi.org/10.1073/pnas.240309797 
Guimarães-Camboa, N., Cattaneo, P., Sun, Y., Moore-Morris, T., Gu, Y., Dalton, N.D., Rockenstein, 
E., Masliah, E., Peterson, K.L., Stallcup, W.B., Chen, J., Evans, S.M., 2017. Pericytes of 
Multiple Organs Do Not Behave as Mesenchymal Stem Cells In Vivo. Cell Stem Cell 20, 345-
359.e5. https://doi.org/10.1016/j.stem.2016.12.006 
Haith, M.M., Benson, J.B., 2008. Encyclopedia of infant and early childhood development, 1st ed. ed. 
Elsevier/Academic Press, Amsterdam Boston. 
Hardy, W.R., Moldovan, N.I., Moldovan, L., Livak, K.J., Datta, K., Goswami, C., Corselli, M., Traktuev, 








Cells Sorted from Human Adipose Tissue Reveal a Hierarchy of Mesenchymal Stem Cells. 
STEM CELLS 35, 1273–1289. https://doi.org/10.1002/stem.2599 
Harvey B., H.B., Flores-Sarnat, L., 2013. Neuropathology of pediatric epilepsy, in: Handbook of Clinical 
Neurology. Elsevier, pp. 399–416. https://doi.org/10.1016/B978-0-444-52891-9.00044-0 
Haurani, M.J., Pagano, P.J., 2007. Adventitial fibroblast reactive oxygen species as autacrine and 
paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc. Res. 75, 679–
689. https://doi.org/10.1016/j.cardiores.2007.06.016 
Haynesworth, S E, Barer, M.A., Caplan, A.I., 1992a. Cell surface antigens on human marrow-derived 
mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69–80. 
https://doi.org/10.1016/8756-3282(92)90363-2 
Haynesworth, S E, Goshima, J., Goldberg, V.M., Caplan, A.I., 1992b. Characterization of cells with 
osteogenic potential from human marrow. Bone 13, 81–88. https://doi.org/10.1016/8756-
3282(92)90364-3 
Haynesworth, S. E., Goshima, J., Goldberg, V.M., Caplan, A.I., 1992a. Characterization of cells with 
osteogenic potential from human marrow. Bone 13, 81–88. https://doi.org/10.1016/8756-
3282(92)90364-3 
Haynesworth, S. E., Goshima, J., Goldberg, V.M., Caplan, A.I., 1992b. Characterization of cells with 
osteogenic potential from human marrow. Bone 13, 81–88. https://doi.org/10.1016/8756-
3282(92)90364-3 
Hellstrom, M., Kal n, M., Lindahl, P., Abramsson, A., Betsholtz, C., 1999. Role of PDGF-B and PDGFR-
beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood 
vessel formation in the mouse. Development 126, 3047–3055. 
https://doi.org/10.1242/dev.126.14.3047 
Hernández, R., Jiménez-Luna, C., Perales-Adán, J., Perazzoli, G., Melguizo, C., Prados, J., 2020. 
Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in 
Nervous System Disorders. Biomol. Ther. 28, 34–44. 
https://doi.org/10.4062/biomolther.2019.065 
Hirschi, K., D’Amore, P., 1996. Pericytes in the microvasculature. Cardiovasc. Res. 
Hu, Xu, 2011. Adventitial Biology. Arterioscler. Thromb. Vasc. Biol. 31, 1523–1529. 
https://doi.org/10.1161/ATVBAHA.110.221176 
Hur, J., Yoon, C.-H., Kim, H.-S., Choi, J.-H., Kang, H.-J., Hwang, K.-K., Oh, B.-H., Lee, M.-M., Park, Y.-
B., 2004. Characterization of Two Types of Endothelial Progenitor Cells and Their Different 
Contributions to Neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 288–293. 
https://doi.org/10.1161/01.ATV.0000114236.77009.06 
Ichihara, Y., Kaneko, M., Yamahara, K., Koulouroudias, M., Sato, N., Uppal, R., Yamazaki, K., Saito, 
S., Suzuki, K., 2018. Self-assembling peptide hydrogel enables instant epicardial coating of the 
heart with mesenchymal stromal cells for the treatment of heart failure. Biomaterials 154, 12–
23. https://doi.org/10.1016/j.biomaterials.2017.10.050 
Ikeda, Hideyoshi, Sumita, Y., Ikeda, M., Ikeda, Hisazumi, Okumura, T., Sakai, E., Nishimura, M., 
Asahina, I., 2011. Engineering Bone Formation from Human Dental Pulp- and Periodontal 
Ligament-Derived Cells. Ann. Biomed. Eng. 39, 26–34. https://doi.org/10.1007/s10439-010-
0115-2 
In ’t Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., de Groot-Swings, G.M.J.S., Claas, F.H.J., 
Fibbe, W.E., Kanhai, H.H.H., 2004. Isolation of mesenchymal stem cells of fetal or maternal 
origin from human placenta. Stem Cells Dayt. Ohio 22, 1338–1345. 
https://doi.org/10.1634/stemcells.2004-0058 
Ishikawa, T., Wondimu, Z., Oikawa, Y., Gentilcore, G., Kiessling, R., Egyhazi Brage, S., Hansson, J., 
Patarroyo, M., 2014. Laminins 411 and 421 differentially promote tumor cell migration via α6β1 
integrin and MCAM (CD146). Matrix Biol. 38, 69–83. 
https://doi.org/10.1016/j.matbio.2014.06.002 
Isobe, Y., Koyama, N., Nakao, K., Osawa, K., Ikeno, M., Yamanaka, S., Okubo, Y., Fujimura, K., 
Bessho, K., 2016. Comparison of human mesenchymal stem cells derived from bone marrow, 
synovial fluid, adult dental pulp, and exfoliated deciduous tooth pulp. Int. J. Oral Maxillofac. 
Surg. 45, 124–131. https://doi.org/10.1016/j.ijom.2015.06.022 
James, A.W., Péault, B., 2019. Perivascular Mesenchymal Progenitors for Bone Regeneration. J. 
Orthop. Res. 37, 1221–1228. https://doi.org/10.1002/jor.24284 
James, A.W., Zhang, X., Crisan, M., Hardy, W.R., Liang, P., Meyers, C.A., Lobo, S., Lagishetty, V., 








Isolation and characterization of canine perivascular stem/stromal cells for bone tissue 
engineering. PLOS ONE 12, e0177308. https://doi.org/10.1371/journal.pone.0177308 
Jeon, S., Lee, H.-S., Lee, G.-Y., Park, G., Kim, T.-M., Shin, J., Lee, C., Oh, I.-H., 2017. Shift of EMT 
gradient in 3D spheroid MSCs for activation of mesenchymal niche function. Sci. Rep. 7, 6859. 
https://doi.org/10.1038/s41598-017-07049-3 
Jessell, T.M., 1988. Adhesion molecules and the hierarchy of neural development. Neuron 1, 3–13. 
https://doi.org/10.1016/0896-6273(88)90204-8 
Jiang, W., Tan, Y., Cai, M., Zhao, T., Mao, F., Zhang, X., Xu, W., Yan, Z., Qian, H., Yan, Y., 2018. 
Human Umbilical Cord MSC-Derived Exosomes Suppress the Development of CCl4-Induced 
Liver Injury through Antioxidant Effect. Stem Cells Int. 2018, 6079642. 
https://doi.org/10.1155/2018/6079642 
Jiang, Y.Q., Oblinger, M.M., 1992. Differential regulation of beta III and other tubulin genes during 
peripheral and central neuron development. J. Cell Sci. 103, 643–651. 
https://doi.org/10.1242/jcs.103.3.643 
Kalinina, N., Kharlampieva, D., Loguinova, M., Butenko, I., Pobeguts, O., Efimenko, A., Ageeva, L., 
Sharonov, G., Ischenko, D., Alekseev, D., Grigorieva, O., Sysoeva, V., Rubina, K., Lazarev, V., 
Govorun, V., 2015. Characterization of secretomes provides evidence for adipose-derived 
mesenchymal stromal cells subtypes. Stem Cell Res. Ther. 6, 221. 
https://doi.org/10.1186/s13287-015-0209-8 
Karaöz, E., Demircan, P.C., Sağlam, O., Aksoy, A., Kaymaz, F., Duruksu, G., 2011. Human dental pulp 
stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-
derived mesenchymal stem cells. Histochem. Cell Biol. 136, 455–473. 
https://doi.org/10.1007/s00418-011-0858-3 
Kaukua, N., Shahidi, M.K., Konstantinidou, C., Dyachuk, V., Kaucka, M., Furlan, A., An, Z., Wang, L., 
Hultman, I., Ährlund-Richter, L., Blom, H., Brismar, H., Lopes, N.A., Pachnis, V., Suter, U., 
Clevers, H., Thesleff, I., Sharpe, P., Ernfors, P., Fried, K., Adameyko, I., 2014. Glial origin of 
mesenchymal stem cells in a tooth model system. Nature 513, 551–554. 
https://doi.org/10.1038/nature13536 
Keating, A., 2012. Mesenchymal stromal cells: new directions. Cell Stem Cell 10, 709–716. 
https://doi.org/10.1016/j.stem.2012.05.015 
Kerkis, I., Ambrosio, C.E., Kerkis, A., Martins, D.S., Zucconi, E., Fonseca, S.A., Cabral, R.M., 
Maranduba, C.M., Gaiad, T.P., Morini, A.C., Vieira, N.M., Brolio, M.P., Sant’Anna, O.A., Miglino, 
M.A., Zatz, M., 2008. Early transplantation of human immature dental pulp stem cells from baby 
teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J. Transl. Med. 
6, 35. https://doi.org/10.1186/1479-5876-6-35 
Kerkis, I., Kerkis, A., Dozortsev, D., Stukart-Parsons, G.C., Gomes Massironi, S.M., Pereira, L.V., 
Caplan, A.I., Cerruti, H.F., 2006. Isolation and characterization of a population of immature 
dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues 
Organs 184, 105–116. https://doi.org/10.1159/000099617 
Kim, B.-C., Bae, H., Kwon, I.-K., Lee, E.-J., Park, J.-H., Khademhosseini, A., Hwang, Y.-S., 2012. 
Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their 
applications to tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 18, 235–
244. https://doi.org/10.1089/ten.TEB.2011.0642 
Kim, H., Bae, C., Kook, Y.-M., Koh, W.-G., Lee, K., Park, M.H., 2019. Mesenchymal stem cell 3D 
encapsulation technologies for biomimetic microenvironment in tissue regeneration. Stem Cell 
Res. Ther. 10, 51. https://doi.org/10.1186/s13287-018-1130-8 
Koç, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., Lazarus, H.M., 
2000. Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and 
Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients 
Receiving High-Dose Chemotherapy. J. Clin. Oncol. 18, 307. 
https://doi.org/10.1200/JCO.2000.18.2.307 
Kode, Jyoti A., Mukherjee, S., Joglekar, M.V., Hardikar, A.A., 2009. Mesenchymal stem cells: 
immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11, 377–
391. https://doi.org/10.1080/14653240903080367 
Kode, Jyoti A, Mukherjee, S., Joglekar, M. V, Hardikar, A.A., 2009. Mesenchymal stem cells: 









Konopleva, M., Mikhail, A., Estrov, Z., Zhao, S., Harris, D., Sanchez-Williams, G., Kornblau, S.M., Dong, 
J., Kliche, K.-O., Jiang, S., Snodgrass, H.R., Estey, E.H., Andreeff, M., 1999. Expression and 
Function of Leptin Receptor Isoforms in Myeloid Leukemia and Myelodysplastic Syndromes: 
Proliferative and Anti-Apoptotic Activities. Blood 93, 1668–1676. 
https://doi.org/10.1182/blood.V93.5.1668 
Krabbe, C., Zimmer, J., Meyer, M., 2005. Neural transdifferentiation of mesenchymal stem cells - a 
critical review. APMIS 113, 831–844. https://doi.org/10.1111/j.1600-0463.2005.apm_3061.x 
Kramann, R., Goettsch, C., Wongboonsin, J., Iwata, H., Schneider, R.K., Kuppe, C., Kaesler, N., 
Chang-Panesso, M., Machado, F.G., Gratwohl, S., Madhurima, K., Hutcheson, J.D., Jain, S., 
Aikawa, E., Humphreys, B.D., 2016. Adventitial MSC-like Cells Are Progenitors of Vascular 
Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease. Cell Stem 
Cell 19, 628–642. https://doi.org/10.1016/j.stem.2016.08.001 
Kramann, R., Schneider, R.K., DiRocco, D.P., Machado, F., Fleig, S., Bondzie, P.A., Henderson, J.M., 
Ebert, B.L., Humphreys, B.D., 2015. Perivascular Gli1+ Progenitors Are Key Contributors to 
Injury-Induced Organ Fibrosis. Cell Stem Cell 16, 51–66. 
https://doi.org/10.1016/j.stem.2014.11.004 
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., Dazzi, F., 2003. Bone marrow 
mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to 
their cognate peptide. Blood 101, 3722–3729. https://doi.org/10.1182/blood-2002-07-2104 
Kuo, M.Y., Lan, W.H., Lin, S.K., Tsai, K.S., Hahn, L.J., 1992. Collagen gene expression in human dental 
pulp cell cultures. Arch. Oral Biol. 37, 945–952. https://doi.org/10.1016/0003-9969(92)90066-h 
Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S.K., Choo, A., Chen, T.S., Salto-Tellez, M., Timmers, L., Lee, 
C.N., El Oakley, R.M., Pasterkamp, G., de Kleijn, D.P. V, Lim, S.K., 2010. Exosome secreted 
by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4, 214–222. 
https://doi.org/10.1016/j.scr.2009.12.003 
Lan, X., Sun, Z., Chu, C., Boltze, J., Li, S., 2019. Dental Pulp Stem Cells: An Attractive Alternative for 
Cell Therapy in Ischemic Stroke. Front. Neurol. 10, 824. 
https://doi.org/10.3389/fneur.2019.00824 
Lazarus, H.M., Haynesworth, S.E., Gerson, S.L., Rosenthal, N.S., Caplan, A.I., 1995. Ex vivo expansion 
and subsequent infusion of human bone marrow-derived stromal progenitor cells 
(mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 16, 
557–564. 
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., Ringdén, O., 2003. HLA expression and 
immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells. Exp. 
Hematol. 31, 890–896. https://doi.org/10.1016/S0301-472X(03)00110-3 
Lee, J.-H., Lee, D.-S., Choung, H.-W., Shon, W.-J., Seo, B.-M., Lee, E.-H., Cho, J.-Y., Park, J.-C., 2011. 
Odontogenic differentiation of human dental pulp stem cells induced by preameloblast-derived 
factors. Biomaterials 32, 9696–9706. https://doi.org/10.1016/j.biomaterials.2011.09.007 
Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Semprun-Prieto, L., Delafontaine, 
P., Prockop, D.J., 2009. Intravenous hMSCs Improve Myocardial Infarction in Mice because 
Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6. Cell 
Stem Cell 5, 54–63. https://doi.org/10.1016/j.stem.2009.05.003 
Liu, Y., Lin, L., Zou, R., Wen, C., Wang, Z., Lin, F., 2018. MSC-derived exosomes promote proliferation 
and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in 
osteoarthritis. Cell Cycle 17, 2411–2422. https://doi.org/10.1080/15384101.2018.1526603 
Lojewski, X., Srimasorn, S., Rauh, J., Francke, S., Wobus, M., Taylor, V., Araúzo-Bravo, M.J., 
Hallmeyer-Elgner, S., Kirsch, M., Schwarz, S., Schwarz, J., Storch, A., Hermann, A., 2015. 
Perivascular Mesenchymal Stem Cells From the Adult Human Brain Harbor No Instrinsic 
Neuroectodermal but High Mesodermal Differentiation Potential. STEM CELLS Transl. Med. 4, 
1223–1233. https://doi.org/10.5966/sctm.2015-0057 
Longoni, A., Utomo, L., van Hooijdonk, I., Bittermann, G., Vetter, V., Kruijt Spanjer, E., Ross, J., 
Rosenberg, A., Gawlitta, D., 2020. The chondrogenic differentiation potential of dental pulp 
stem cells. Eur. Cell. Mater. 39, 121–135. https://doi.org/10.22203/eCM.v039a08 
Majesky, M.W., Dong, X.R., Hoglund, V., Mahoney Jr, W.M., Daum, G., 2011. The Adventitia: A 
Dynamic Interface Containing Resident Progenitor Cells. 
https://doi.org/10.1161/ATVBAHA.110.221549 
Majumdar, M.K., Thiede, M.A., Mosca, J.D., Moorman, M., Gerson, S.L., 1998. Phenotypic and 








stromal cells. J. Cell. Physiol. 176, 57–66. https://doi.org/10.1002/(SICI)1097-
4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7 
Martin, P.J., Uberti, J.P., Soiffer, R.J., Klingemann, H., Waller, E.K., Daly, A.S., Herrmann, R.P., 
Kebriaei, P., 2010. Prochymal Improves Response Rates In Patients With Steroid-Refractory 
Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A 
Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD. Biol. Blood Marrow 
Transplant. 16, S169–S170. https://doi.org/10.1016/j.bbmt.2009.12.057 
Martín-González, Jénifer, Pérez-Pérez, A., Sánchez-Jiménez, F., Carmona-Fernández, A., Torres-
Lagares, D., Sánchez-Margalet, V., Segura-Egea, J.J., 2013. Leptin Receptor Is Up-regulated 
in Inflamed Human Dental Pulp. J. Endod. 39, 1567–1571. 
https://doi.org/10.1016/j.joen.2013.08.014 
Martín-González, J., Sánchez-Jiménez, F., Pérez-Pérez, A., Carmona-Fernández, A., Sánchez-
Margalet, V., Segura-Egea, J.J., 2013. Leptin expression in healthy and inflamed human dental 
pulp. Int. Endod. J. 46, 442–448. https://doi.org/10.1111/iej.12009 
Martin-Piedra, M.A., Garzon, I., Oliveira, A.C., Alfonso-Rodriguez, C.A., Carriel, V., Scionti, G., 
Alaminos, M., 2014. Cell viability and proliferation capability of long-term human dental pulp 
stem cell cultures. Cytotherapy 16, 266–277. https://doi.org/10.1016/j.jcyt.2013.10.016 
Martin-Piedra, M.A., Garzon, I., Oliveira, A.C., Alfonso-Rodriguez, C.A., Sanchez-Quevedo, M.C., 
Campos, A., Alaminos, M., 2013. Average cell viability levels of human dental pulp stem cells: 
an accurate combinatorial index for quality control in tissue engineering. Cytotherapy 15, 507–
518. https://doi.org/10.1016/j.jcyt.2012.11.017 
Mattei, V., Martellucci, S., Pulcini, F., Santilli, F., Sorice, M., Delle Monache, S., 2021. Regenerative 
Potential of DPSCs and Revascularization: Direct, Paracrine or Autocrine Effect? Stem Cell 
Rev. Rep. https://doi.org/10.1007/s12015-021-10162-6 
Meirelles, L. da S., Chagastelles, P.C., Nardi, N.B., 2006. Mesenchymal stem cells reside in virtually all 
post-natal organs and tissues. J. Cell Sci. 119, 2204 LP – 2213. 
https://doi.org/10.1242/jcs.02932 
Monteiro, B.G., Serafim, R.C., Melo, G.B., Silva, M.C.P., Lizier, N.F., Maranduba, C.M.C., Smith, R.L., 
Kerkis, A., Cerruti, H., Gomes, J. a. P., Kerkis, I., 2009. Human immature dental pulp stem cells 
share key characteristic features with limbal stem cells. Cell Prolif. 42, 587–594. 
https://doi.org/10.1111/j.1365-2184.2009.00623.x 
Monterubbianesi, R., Bencun, M., Pagella, P., Woloszyk, A., Orsini, G., Mitsiadis, T.A., 2019. A 
comparative in vitro study of the osteogenic and adipogenic potential of human dental pulp 
stem cells, gingival fibroblasts and foreskin fibroblasts. Sci. Rep. 9, 1761. 
https://doi.org/10.1038/s41598-018-37981-x 
Moreno, P.R., Purushothaman, K.R., Zias, E., Fuster, J.S. and V, 2006. Neovascularization in Human 
Atherosclerosis. Curr. Mol. Med. http://dx.doi.org/10.2174/156652406778018635 
Mouser, V.H.M., Levato, R., Mensinga, A., Dhert, W.J.A., Gawlitta, D., Malda, J., 2018. Bio-ink 
development for three-dimensional bioprinting of hetero-cellular cartilage constructs. Connect. 
Tissue Res. 61, 137–151. https://doi.org/10.1080/03008207.2018.1553960 
Muraglia, A., Cancedda, R., Quarto, R., 2000. Clonal mesenchymal progenitors from human bone 
marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 113, 1161 LP – 1166. 
Murfee, W.L., Rehorn, M.R., Peirce, S.M., Skalak, T.C., 2006. Perivascular Cells Along Venules 
Upregulate NG2 Expression During Microvascular Remodeling. Microcirculation 13, 261–273. 
https://doi.org/10.1080/10739680600559153 
Murfee, W.L., Skalak, T.C., Peirce, S.M., 2005. Differential Arterial/Venous Expression of NG2 
Proteoglycan in Perivascular Cells Along Microvessels: Identifying a Venule-Specific 
Phenotype. Microcirculation 12, 151–160. https://doi.org/10.1080/10739680590904955 
Murray, Iain R, Péault, B., 2015. Q&A: Mesenchymal stem cells — where do they come from and is it 
important? BMC Biol. 13, 99. https://doi.org/10.1186/s12915-015-0212-7 
Murray, Iain R., Péault, B., 2015. Q&A: Mesenchymal stem cells - where do they come from and is it 
important? BMC Biol. 13, 99. https://doi.org/10.1186/s12915-015-0212-7 
Nadri, S., Soleimani, M., 2007. Comparative analysis of mesenchymal stromal cells from murine bone 
marrow and amniotic fluid. Cytotherapy 9, 729–737. 
https://doi.org/10.1080/14653240701656061 
Nakashima, M., Iohara, K., Sugiyama, M., 2009. Human dental pulp stem cells with highly angiogenic 
and neurogenic potential for possible use in pulp regeneration. Cytokine Growth Factor Rev. 








Nanci, A., Bosshardt, D.D., 2006. Structure of periodontal tissues in health and disease*. Periodontol. 
2000 40, 11–28. https://doi.org/10.1111/j.1600-0757.2005.00141.x 
Nauta, A.J., Fibbe, W.E., 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 
110, 3499–3506. https://doi.org/10.1182/blood-2007-02-069716 
Nayak, R.C., Berman, A.B., George, K.L., Eisenbarth, G.S., King, G.L., 1988. A monoclonal antibody 
(3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. 
J. Exp. Med. 167, 1003–1015. https://doi.org/10.1084/jem.167.3.1003 
Németh, K., Leelahavanichkul, A., Yuen, P.S.T., Mayer, B., Parmelee, A., Doi, K., Robey, P.G., 
Leelahavanichkul, K., Koller, B.H., Brown, J.M., Hu, X., Jelinek, I., Star, R.A., Mezey, É., 2009. 
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming 
of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42–49. 
https://doi.org/10.1038/nm.1905 
Nito, C., Sowa, K., Nakajima, M., Sakamoto, Y., Suda, S., Nishiyama, Y., Nakamura-Takahashi, A., 
Nitahara-Kasahara, Y., Ueda, M., Okada, T., Kimura, K., 2018. Transplantation of human dental 
pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed. 
Pharmacother. 108, 1005–1014. https://doi.org/10.1016/j.biopha.2018.09.084 
Owen, M., Friedenstein, A.J., 1988. Stromal Stem Cells: Marrow-Derived Osteogenic Precursors. Ciba 
Found. Symp. 136 - Cell Mol. Biol. Vertebr. Hard Tissues, Novartis Foundation Symposia. 
https://doi.org/doi:10.1002/9780470513637.ch4 
Paino, F., La Noce, M., Giuliani, A., De Rosa, A., Mazzoni, S., Laino, L., Amler, E., Papaccio, G., 
Desiderio, V., Tirino, V., 2017. Human DPSCs fabricate vascularized woven bone tissue: a new 
tool in bone tissue engineering. Clin. Sci. 131, 699–713. https://doi.org/10.1042/CS20170047 
Park, K.M., Shin, Y.M., Kim, K., Shin, H., 2018. Tissue Engineering and Regenerative Medicine 2017: 
A Year in Review. Tissue Eng. Part B Rev. 24, 327–344. 
https://doi.org/10.1089/ten.teb.2018.0027 
Péault, B., Rudnicki, M., Torrente, Y., Cossu, G., Tremblay, J.P., Partridge, T., Gussoni, E., Kunkel, 
L.M., Huard, J., 2007. Stem and Progenitor Cells in Skeletal Muscle Development, 
Maintenance, and Therapy. Mol. Ther. 15, 867–877. https://doi.org/10.1038/mt.sj.6300145 
Penna, V., Lipay, M.V.N., Duailibi, M.T., Duailibi, S.E., 2015. The likely role of proteolytic enzymes in 
unwanted differentiation of stem cells in culture. Future Sci. OA 1. 
https://doi.org/10.4155/fso.15.26 
Piersma, A.H., Ploemacher, R.E., Brockbank, K.G.M., Nikkels, P.G.J., Ottenheim, C.P.E., 1985. 
Migration of Fibroblastoid Stromal Cells In Murine Blood. Cell Prolif. 18, 589–595. 
https://doi.org/10.1111/j.1365-2184.1985.tb00702.x 
Pinnock, C.B., Meier, E.M., Joshi, N.N., Wu, B., Lam, M.T., 2016. Customizable engineered blood 
vessels using 3D printed inserts. Methods 99, 20–27. 
https://doi.org/10.1016/j.ymeth.2015.12.015 
Pisciotta, A., Carnevale, G., Meloni, S., Riccio, M., De Biasi, S., Gibellini, L., Ferrari, A., Bruzzesi, G., 
De Pol, A., 2015. Human Dental pulp stem cells (hDPSCs): isolation, enrichment and 
comparative differentiation of two sub-populations. BMC Dev. Biol. 15, 14. 
https://doi.org/10.1186/s12861-015-0065-x 
Pittenger, M.F., Discher, D.E., Péault, B.M., Phinney, D.G., Hare, J.M., Caplan, A.I., 2019. 
Mesenchymal stem cell perspective: cell biology to clinical progress. Npj Regen. Med. 4, 22. 
https://doi.org/10.1038/s41536-019-0083-6 
Pittenger, Mark F, Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., 
Simonetti, D.W., Craig, S., Marshak, D.R., 1999. Multilineage Potential of Adult Human 
Mesenchymal Stem Cells. Science 284, 143 LP – 147. 
https://doi.org/10.1126/science.284.5411.143 
Pittenger, M. F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., 
Simonetti, D.W., Craig, S., Marshak, D.R., 1999. Multilineage potential of adult human 
mesenchymal stem cells. Science 284, 143–147. 
https://doi.org/10.1126/science.284.5411.143 
Plappert, C.F., Schachner, M., Pilz, P.K.D., 2005. Neural cell adhesion molecule (NCAM -/- ) null mice 
show impaired sensitization of the startle response: Impaired sensitization in NCAM knockouts. 
Genes Brain Behav. 5, 46–52. https://doi.org/10.1111/j.1601-183X.2005.00132.x 
Poldervaart, M.T., Goversen, B., de Ruijter, M., Abbadessa, A., Melchels, F.P.W., Öner, F.C., Dhert, 
W.J.A., Vermonden, T., Alblas, J., 2017. 3D bioprinting of methacrylated hyaluronic acid 








Rafiee, F., Pourteymourfard-Tabrizi, Z., Mahmoudian-Sani, M.-R., Mehri-Ghahfarrokhi, A., Soltani, A., 
Hashemzadeh-Chaleshtori, M., Jami, M.-S., 2020. Differentiation of dental pulp stem cells into 
neuron-like cells. Int. J. Neurosci. 130, 107–116. 
https://doi.org/10.1080/00207454.2019.1664518 
Rafii, S., Lyden, D., 2003. Therapeutic stem and progenitor cell transplantation for organ vascularization 
and regeneration. Nat. Med. 9, 702–712. https://doi.org/10.1038/nm0603-702 
Rashedi, I., Talele, N., Wang, X.-H., Hinz, B., Radisic, M., Keating, A., 2017. Collagen scaffold 
enhances the regenerative properties of mesenchymal stromal cells. PLOS ONE 12, 
e0187348. 
Reicin, C., McMahon, E., Chung, C., 2012. Stem cell therapy regulation in Canada: implications of the 
prochymal approval. Westlaw J. 
Robbins, S.G., Mixon, R.N., Wilson, D.J., Hart, C.E., Robertson, J.E., Westra, I., Planck, S.R., 1994. 
Platelet-Derived Growth Factor Ligands and Receptors Immunolocalized in Proliferative Retinal 
Diseases. Invest. Ophthalmol. 35, 15. 
Rodeheffer, M.S., Birsoy, K., Friedman, J.M., 2008. Identification of White Adipocyte Progenitor Cells 
In Vivo. Cell 135, 240–249. https://doi.org/10.1016/j.cell.2008.09.036 
Rodriguez, A.-M., Elabd, C., Amri, E.-Z., Ailhaud, G., Dani, C., 2005. The human adipose tissue is a 
source of multipotent stem cells. Biochimie 87, 125–128. 
https://doi.org/10.1016/j.biochi.2004.11.007 
Rosado, M.M., Bernardo, M.E., Scarsella, M., Conforti, A., Giorda, E., Biagini, S., Cascioli, S., Rossi, 
F., Guzzo, I., Vivarelli, M., Dello Strologo, L., Emma, F., Locatelli, F., Carsetti, R., 2014. 
Inhibition of B-Cell Proliferation and Antibody Production by Mesenchymal Stromal Cells Is 
Mediated by T Cells. Stem Cells Dev. 24, 93–103. https://doi.org/10.1089/scd.2014.0155 
Rouget, 1873. Memoire sur le developpement, de la structure et les proprietes physiologiques des 
capillaires sanguins et lympha-tiques. Arch. Physiol. Norm. Path. 5, 603–663. 
Rucker, H.K., Wynder, H.J., Thomas, W.E., 2000. Cellular mechanisms of CNS pericytes. Brain Res. 
Bull. 51, 363–369. https://doi.org/10.1016/S0361-9230(99)00260-9 
Ryan, J.M., Barry, F., Murphy, J.M., Mahon, B.P., 2007. Interferon-γ does not break, but promotes the 
immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 
149, 353–363. https://doi.org/10.1111/j.1365-2249.2007.03422.x 
Sagar, R., Walther-Jallow, L., David, A.L., Götherström, C., Westgren, M., 2018. Fetal Mesenchymal 
Stromal Cells: an Opportunity for Prenatal Cellular Therapy. Curr. Stem Cell Rep. 4, 61–68. 
https://doi.org/10.1007/s40778-018-0118-8 
Saito, M.T., 2015. Tooth-derived stem cells: Update and perspectives. World J. Stem Cells 7, 399. 
https://doi.org/10.4252/wjsc.v7.i2.399 
Sasaki, R., Aoki, S., Yamato, M., Uchiyama, H., Wada, K., Okano, T., Ogiuchi, H., 2008. Neurosphere 
generation from dental pulp of adult rat incisor. Eur. J. Neurosci. 27, 538–548. 
https://doi.org/10.1111/j.1460-9568.2008.06026.x 
Selich, A., Daudert, J., Hass, R., Philipp, F., von Kaisenberg, C., Paul, G., Cornils, K., Fehse, B., 
Rittinghausen, S., Schambach, A., Rothe, M., 2016. Massive Clonal Selection and Transiently 
Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by 
Lentiviral RGB-Barcode Technology. STEM CELLS Transl. Med. 5, 591–601. 
https://doi.org/10.5966/sctm.2015-0176 
Seo, B.-M., Miura, M., Gronthos, S., Mark Bartold, P., Batouli, S., Brahim, J., Young, M., Gehron Robey, 
P., Wang, C.Y., Shi, S., 2004. Investigation of multipotent postnatal stem cells from human 
periodontal ligament. The Lancet 364, 149–155. https://doi.org/10.1016/S0140-
6736(04)16627-0 
Sheridan, C., 2018. First off-the-shelf mesenchymal stem cell therapy nears European approval. Nat. 
Biotechnol. 36, 212–214. https://doi.org/10.1038/nbt0318-212a 
Shi, S., Gronthos, S., 2003a. Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone 
Marrow and Dental Pulp. J. Bone Miner. Res. 18, 696–704. 
https://doi.org/10.1359/jbmr.2003.18.4.696 
Shi, S., Gronthos, S., 2003b. Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone 
Marrow and Dental Pulp. J. Bone Miner. Res. 18, 696–704. 
https://doi.org/10.1359/jbmr.2003.18.4.696 
Shi, X., Mao, J., Liu, Y., 2020. Pulp stem cells derived from human permanent and deciduous teeth: 









Shigemoto-Kuroda, T., Oh, J.Y., Kim, D., Jeong, H.J., Park, S.Y., Lee, H.J., Park, J.W., Kim, T.W., An, 
S.Y., Prockop, D.J., Lee, R.H., 2017. MSC-derived Extracellular Vesicles Attenuate Immune 
Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis. Stem Cell 
Rep. 8, 1214–1225. https://doi.org/10.1016/j.stemcr.2017.04.008 
Shih, 1999. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 8. 
Shih, D.T., Lee, D.-C., Chen, S.-C., Tsai, R.-Y., Huang, C.-T., Tsai, C.-C., Shen, E.-Y., Chiu, W.-T., 
2005. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp 
tissue. Stem Cells Dayt. Ohio 23, 1012–1020. https://doi.org/10.1634/stemcells.2004-0125 
Siow, R.C.M., Mallawaarachchi, C.M., Weissberg, P.L., 2003. Migration of adventitial myofibroblasts 
following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries. 
Cardiovasc. Res. 59, 212–221. https://doi.org/10.1016/S0008-6363(03)00292-X 
Sipp, D., 2015. Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products. Cell 
Stem Cell 16, 353–356. https://doi.org/10.1016/j.stem.2015.03.013 
Song, M., Lee, J.-H., Bae, J., Bu, Y., Kim, E.-C., 2017. Human Dental Pulp Stem Cells are more 
Effective than Human Bone Marrow-Derived Mesenchymal Stem Cells in Cerebral Ischemic 
Injury. Cell Transplant. 26, 1001–1016. https://doi.org/10.3727/096368916X694391 
Sorrell, J.M., Baber, M.A., Caplan, A.I., 2009. Influence of Adult Mesenchymal Stem Cells on In Vitro 
Vascular Formation. Tissue Eng. Part A 15, 1751–1761. 
https://doi.org/10.1089/ten.tea.2008.0254 
Spaggiari, G.M., Abdelrazik, H., Becchetti, F., Moretta, L., 2009. MSCs inhibit monocyte-derived DC 
maturation and function by selectively interfering with the generation of immature DCs: central 
role of MSC-derived prostaglandin E2. Blood 113, 6576–6583. https://doi.org/10.1182/blood-
2009-02-203943 
Stallcup, W.B., Huang, F.-J., 2008. A role for the NG2 proteoglycan in glioma progression. Cell Adhes. 
Migr. 2, 192–201. https://doi.org/10.4161/cam.2.3.6279 
Stapor, P.C., Sweat, R.S., Dashti, D.C., Betancourt, A.M., Murfee, W.L., 2014. Pericyte Dynamics 
during Angiogenesis: New Insights from New Identities. J. Vasc. Res. 51, 163–174. 
https://doi.org/10.1159/000362276 
Stenmark, K.R., Davie, N., Frid, M., Gerasimovskaya, E., Das, M., 2006. Role of the Adventitia in 
Pulmonary Vascular Remodeling. Physiology 21, 134–145. 
https://doi.org/10.1152/physiol.00053.2005 
Stenmark, K.R., Yeager, M.E., El Kasmi, K.C., Nozik-Grayck, E., Gerasimovskaya, E. V, Li, M., Riddle, 
S.R., Frid, M.G., 2013. The Adventitia: Essential Regulator of Vascular Wall Structure and 
Function. Annu. Rev. Physiol. 75, 23–47. https://doi.org/10.1146/annurev-physiol-030212-
183802 
Suchánek, J., Visek, B., Soukup, T., El-Din Mohamed, S.K., Ivancaková, R., Mokrỳ, J., Aboul-Ezz, 
E.H.A., Omran, A., 2010. Stem cells from human exfoliated deciduous teeth--isolation, long 
term cultivation and phenotypical analysis. Acta Medica (Hradec Kralove) 53, 93–99. 
https://doi.org/10.14712/18059694.2016.66 
Sun, H.-H., Chen, B., Zhu, Q.-L., Kong, H., Li, Q.-H., Gao, L.-N., Xiao, M., Chen, F.-M., Yu, Q., 2014. 
Investigation of dental pulp stem cells isolated from discarded human teeth extracted due to 
aggressive periodontitis. Biomaterials 35, 9459–9472. 
https://doi.org/10.1016/j.biomaterials.2014.08.003 
Takeyasu, M., Nozaki, T., Daito, M., 2006. Differentiation of dental pulp stem cells into a neural lineage. 
Pediatr. Dent. J. 16, 154–162. https://doi.org/10.1016/S0917-2394(06)70081-7 
Tamaki, Y., Nakahara, T., Ishikawa, H., Sato, S., 2013. In vitro analysis of mesenchymal stem cells 
derived from human teeth and bone marrow. Odontology 101, 121–132. 
https://doi.org/10.1007/s10266-012-0075-0 
Tamaoki, N., Takahashi, K., Tanaka, T., Ichisaka, T., Aoki, H., Takeda-Kawaguchi, T., Iida, K., 
Kunisada, T., Shibata, T., Yamanaka, S., Tezuka, K., 2010. Dental pulp cells for induced 
pluripotent stem cell banking. J. Dent. Res. 89, 773–778. 
https://doi.org/10.1177/0022034510366846 
Tang, W., Zeve, D., Suh, J.M., Bosnakovski, D., Kyba, M., Hammer, R.E., Tallquist, M.D., Graff, J.M., 
2008. White Fat Progenitor Cells Reside in the Adipose Vasculature. Science 322, 583 LP – 
586. https://doi.org/10.1126/science.1156232 









Téclès, O., Laurent, P., Zygouritsas, S., Burger, A.-S., Camps, J., Dejou, J., About, I., 2005. Activation 
of human dental pulp progenitor/stem cells in response to odontoblast injury. Arch. Oral Biol. 
50, 103–108. https://doi.org/10.1016/j.archoralbio.2004.11.009 
Ten Cate, A.R., 1998. Oral histology: development, structure, and function, 5th ed. ed. Mosby, St. Louis. 
Théry, C., Witwer, K.W., Aikawa, E., Alcaraz, M.J., Anderson, J.D., Andriantsitohaina, R., Antoniou, A., 
Arab, T., Archer, F., Atkin-Smith, G.K., Ayre, D.C., Bach, J.-M., Bachurski, D., Baharvand, H., 
Balaj, L., Baldacchino, S., Bauer, N.N., Baxter, A.A., Bebawy, M., Beckham, C., Bedina Zavec, 
A., Benmoussa, A., Berardi, A.C., Bergese, P., Bielska, E., Blenkiron, C., Bobis-Wozowicz, S., 
Boilard, E., Boireau, W., Bongiovanni, A., Borràs, F.E., Bosch, S., Boulanger, C.M., Breakefield, 
X., Breglio, A.M., Brennan, M.Á., Brigstock, D.R., Brisson, A., Broekman, M.L.D., Bromberg, 
J.F., Bryl-Górecka, P., Buch, S., Buck, A.H., Burger, D., Busatto, S., Buschmann, D., Bussolati, 
B., Buzás, E.I., Byrd, J.B., Camussi, G., Carter, D.R.F., Caruso, S., Chamley, L.W., Chang, Y.-
T., Chen, C., Chen, S., Cheng, L., Chin, A.R., Clayton, A., Clerici, S.P., Cocks, A., Cocucci, E., 
Coffey, R.J., Cordeiro-da-Silva, A., Couch, Y., Coumans, F.A.W., Coyle, B., Crescitelli, R., 
Criado, M.F., D’Souza-Schorey, C., Das, S., Datta Chaudhuri, A., de Candia, P., De Santana, 
E.F., De Wever, O., del Portillo, H.A., Demaret, T., Deville, S., Devitt, A., Dhondt, B., Di Vizio, 
D., Dieterich, L.C., Dolo, V., Dominguez Rubio, A.P., Dominici, M., Dourado, M.R., Driedonks, 
T.A.P., Duarte, F. V, Duncan, H.M., Eichenberger, R.M., Ekström, K., EL Andaloussi, S., Elie-
Caille, C., Erdbrügger, U., Falcón-Pérez, J.M., Fatima, F., Fish, J.E., Flores-Bellver, M., 
Försönits, A., Frelet-Barrand, A., Fricke, F., Fuhrmann, G., Gabrielsson, S., Gámez-Valero, A., 
Gardiner, C., Gärtner, K., Gaudin, R., Gho, Y.S., Giebel, B., Gilbert, C., Gimona, M., Giusti, I., 
Goberdhan, D.C.I., Görgens, A., Gorski, S.M., Greening, D.W., Gross, J.C., Gualerzi, A., 
Gupta, G.N., Gustafson, D., Handberg, A., Haraszti, R.A., Harrison, P., Hegyesi, H., Hendrix, 
A., Hill, A.F., Hochberg, F.H., Hoffmann, K.F., Holder, B., Holthofer, H., Hosseinkhani, B., Hu, 
G., Huang, Y., Huber, V., Hunt, S., Ibrahim, A.G.-E., Ikezu, T., Inal, J.M., Isin, M., Ivanova, A., 
Jackson, H.K., Jacobsen, S., Jay, S.M., Jayachandran, M., Jenster, G., Jiang, L., Johnson, 
S.M., Jones, J.C., Jong, A., Jovanovic-Talisman, T., Jung, S., Kalluri, R., Kano, S., Kaur, S., 
Kawamura, Y., Keller, E.T., Khamari, D., Khomyakova, E., Khvorova, A., Kierulf, P., Kim, K.P., 
Kislinger, T., Klingeborn, M., Klinke, D.J., Kornek, M., Kosanović, M.M., Kovács, Á.F., Krämer-
Albers, E.-M., Krasemann, S., Krause, M., Kurochkin, I. V, Kusuma, G.D., Kuypers, S., Laitinen, 
S., Langevin, S.M., Languino, L.R., Lannigan, J., Lässer, C., Laurent, L.C., Lavieu, G., Lázaro-
Ibáñez, E., Le Lay, S., Lee, M.-S., Lee, Y.X.F., Lemos, D.S., Lenassi, M., Leszczynska, A., Li, 
I.T.S., Liao, K., Libregts, S.F., Ligeti, E., Lim, R., Lim, S.K., Linē, A., Linnemannstöns, K., 
Llorente, A., Lombard, C.A., Lorenowicz, M.J., Lörincz, Á.M., Lötvall, J., Lovett, J., Lowry, M.C., 
Loyer, X., Lu, Q., Lukomska, B., Lunavat, T.R., Maas, S.L.N., Malhi, H., Marcilla, A., Mariani, 
J., Mariscal, J., Martens-Uzunova, E.S., Martin-Jaular, L., Martinez, M.C., Martins, V.R., 
Mathieu, M., Mathivanan, S., Maugeri, M., McGinnis, L.K., McVey, M.J., Meckes, D.G., 
Meehan, K.L., Mertens, I., Minciacchi, V.R., Möller, A., Møller Jørgensen, M., Morales-
Kastresana, A., Morhayim, J., Mullier, F., Muraca, M., Musante, L., Mussack, V., Muth, D.C., 
Myburgh, K.H., Najrana, T., Nawaz, M., Nazarenko, I., Nejsum, P., Neri, C., Neri, T., Nieuwland, 
R., Nimrichter, L., Nolan, J.P., Nolte-’t Hoen, E.N.M., Noren Hooten, N., O’Driscoll, L., O’Grady, 
T., O’Loghlen, A., Ochiya, T., Olivier, M., Ortiz, A., Ortiz, L.A., Osteikoetxea, X., Østergaard, 
O., Ostrowski, M., Park, J., Pegtel, D.M., Peinado, H., Perut, F., Pfaffl, M.W., Phinney, D.G., 
Pieters, B.C.H., Pink, R.C., Pisetsky, D.S., Pogge von Strandmann, E., Polakovicova, I., Poon, 
I.K.H., Powell, B.H., Prada, I., Pulliam, L., Quesenberry, P., Radeghieri, A., Raffai, R.L., 
Raimondo, S., Rak, J., Ramirez, M.I., Raposo, G., Rayyan, M.S., Regev-Rudzki, N., Ricklefs, 
F.L., Robbins, P.D., Roberts, D.D., Rodrigues, S.C., Rohde, E., Rome, S., Rouschop, K.M.A., 
Rughetti, A., Russell, A.E., Saá, P., Sahoo, S., Salas-Huenuleo, E., Sánchez, C., Saugstad, 
J.A., Saul, M.J., Schiffelers, R.M., Schneider, R., Schøyen, T.H., Scott, A., Shahaj, E., Sharma, 
S., Shatnyeva, O., Shekari, F., Shelke, G.V., Shetty, A.K., Shiba, K., Siljander, P.R.-M., Silva, 
A.M., Skowronek, A., Snyder, O.L., Soares, R.P., Sódar, B.W., Soekmadji, C., Sotillo, J., Stahl, 
P.D., Stoorvogel, W., Stott, S.L., Strasser, E.F., Swift, S., Tahara, H., Tewari, M., Timms, K., 
Tiwari, S., Tixeira, R., Tkach, M., Toh, W.S., Tomasini, R., Torrecilhas, A.C., Tosar, J.P., 
Toxavidis, V., Urbanelli, L., Vader, P., van Balkom, B.W.M., van der Grein, S.G., Van Deun, J., 
van Herwijnen, M.J.C., Van Keuren-Jensen, K., van Niel, G., van Royen, M.E., van Wijnen, 
A.J., Vasconcelos, M.H., Vechetti, I.J., Veit, T.D., Vella, L.J., Velot, É., Verweij, F.J., Vestad, 
B., Viñas, J.L., Visnovitz, T., Vukman, K. V, Wahlgren, J., Watson, D.C., Wauben, M.H.M., 








Wheelock, A.M., Wiener, Z., Witte, L., Wolfram, J., Xagorari, A., Xander, P., Xu, J., Yan, X., 
Yáñez-Mó, M., Yin, H., Yuana, Y., Zappulli, V., Zarubova, J., Žėkas, V., Zhang, J., Zhao, Z., 
Zheng, L., Zheutlin, A.R., Zickler, A.M., Zimmermann, P., Zivkovic, A.M., Zocco, D., Zuba-
Surma, E.K., 2018. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): 
a position statement of the International Society for Extracellular Vesicles and update of the 
MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750. 
https://doi.org/10.1080/20013078.2018.1535750 
Thesleff, I., 2008. Tooth organogenesis and regeneration. StemBook. 
https://doi.org/10.3824/stembook.1.37.1 
Tormin, A., Li, O., Brune, J.C., Walsh, S., Schütz, B., Ehinger, M., Ditzel, N., Kassem, M., Scheding, 
S., 2011. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated 
with in situ localization. Blood 117, 5067–5077. https://doi.org/10.1182/blood-2010-08-304287 
Tucker, A., Sharpe, P., 2004. The cutting-edge of mammalian development; how the embryo makes 
teeth. Nat. Rev. Genet. 5, 499–508. https://doi.org/10.1038/nrg1380 
Ullah, I., Subbarao, R.B., Kim, E.-J., Bharti, D., Jang, S.-J., Park, J.-S., Shivakumar, S.B., Lee, S.-L., 
Kang, D., Byun, J.-H., Park, B.-W., Rho, G.-J., 2016. In vitro comparative analysis of human 
dental stem cells from a single donor and its neuronal differentiation potential evaluated by 
electrophysiology. Life Sci. 154, 39–51. https://doi.org/10.1016/j.lfs.2016.04.026 
Vezzani, B., Shaw, I., Lesme, H., Yong, L., Khan, N., Tremolada, C., Péault, B., 2018. Higher Pericyte 
Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to 
Enzymatically Derived Stromal Vascular Fraction. STEM CELLS Transl. Med. 7, 876–886. 
https://doi.org/10.1002/sctm.18-0051 
von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., Le Blanc, 
K., 2012. Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans 
Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation. STEM CELLS 30, 
1575–1578. https://doi.org/10.1002/stem.1118 
Wakitani, S., Imoto, K., Yamamoto, T., Saito, M., Murata, N., Yoneda, M., 2002. Human autologous 
culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects 
in osteoarthritic knees. Osteoarthritis Cartilage 10, 199–206. 
https://doi.org/10.1053/joca.2001.0504 
Wang, J., Liu, X., Jin, X., Ma, H., Hu, J., Ni, L., Ma, P.X., 2010. The odontogenic differentiation of human 
dental pulp stem cells on nanofibrous poly(l-lactic acid) scaffolds in vitro and in vivo. Acta 
Biomater. 6, 3856–3863. https://doi.org/10.1016/j.actbio.2010.04.009 
Wang, Y., Xu, J., Chang, L., Meyers, C.A., Zhang, L., Broderick, K., Lee, M., Peault, B., James, A.W., 
2019. Relative contributions of adipose-resident CD146+ pericytes and CD34+ adventitial 
progenitor cells in bone tissue engineering. Npj Regen. Med. 4, 1. 
https://doi.org/10.1038/s41536-018-0063-2 
Witt, R., Weigand, A., Boos, A.M., Cai, A., Dippold, D., Boccaccini, A.R., Schubert, D.W., Hardt, M., 
Lange, C., Arkudas, A., Horch, R.E., Beier, J.P., 2017. Mesenchymal stem cells and myoblast 
differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering. BMC 
Cell Biol. 18, 15. https://doi.org/10.1186/s12860-017-0131-2 
Xu, J., Wang, Y., Hsu, C.-Y., Gao, Y., Meyers, C.A., Chang, L., Zhang, L., Broderick, K., Ding, C., 
Peault, B., Witwer, K., James, A.W., 2019. Human perivascular stem cell-derived extracellular 
vesicles mediate bone repair. eLife 8, e48191. https://doi.org/10.7554/eLife.48191 
Xu, J., Wang, Y., Hsu, C.-Y., Negri, S., Tower, R.J., Gao, Y., Tian, Y., Sono, T., Meyers, C.A., Hardy, 
W.R., Chang, L., Hu, S., Kahn, N., Broderick, K., Péault, B., James, A.W., 2020. Lysosomal 
protein surface expression discriminates fat- from bone-forming human mesenchymal 
precursor cells. eLife 9, e58990. https://doi.org/10.7554/eLife.58990 
Xu, Y., Malladi, P., Wagner, D.R., Longaker, M.T., 2005. Adipose-derived mesenchymal cells as a 
potential cell source for skeletal regeneration. Curr. Opin. Mol. Ther. 7, 300—305. 
Yamazaki, H., Sakata, E., Yamane, T., Yanagisawa, A., Abe, K., Yamamura, K.-I., Hayashi, S.-I., 
Kunisada, T., 2005. Presence and distribution of neural crest-derived cells in the murine 
developing thymus and their potential for differentiation. Int. Immunol. 17, 549–558. 
https://doi.org/10.1093/intimm/dxh237 
Yang, C., Li, X., Sun, L., Guo, W., Tian, W., 2017. Potential of human dental stem cells in repairing the 









Yang, X., Walboomers, X.F., van den Beucken, J.J.J.P., Bian, Z., Fan, M., Jansen, J.A., 2009. Hard 
tissue formation of STRO-1-selected rat dental pulp stem cells in vivo. Tissue Eng. Part A 15, 
367–375. https://doi.org/10.1089/ten.tea.2008.0133 
Yang, Y., Ye, Y., Su, X., He, J., Bai, W., He, X., 2017. MSCs-Derived Exosomes and 
Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front. Cell. Neurosci. 
11, 55. https://doi.org/10.3389/fncel.2017.00055 
Yawata, T., Higashi, Y., Kawanishi, Y., Nakajo, T., Fukui, N., Fukuda, H., Ueba, T., 2019. CD146 is 
highly expressed in glioma stem cells and acts as a cell cycle regulator. J. Neurooncol. 144, 
21–32. https://doi.org/10.1007/s11060-019-03200-4 
Yi, Q., Liu, O., Yan, F., Lin, X., Diao, S., Wang, L., Jin, L., Wang, S., Lu, Y., Fan, Z., 2017a. Analysis of 
Senescence-Related Differentiation Potentials and Gene Expression Profiles in Human Dental 
Pulp Stem Cells. Cells Tissues Organs 203, 1–11. https://doi.org/10.1159/000448026 
Yi, Q., Liu, O., Yan, F., Lin, X., Diao, S., Wang, L., Jin, L., Wang, S., Lu, Y., Fan, Z., 2017b. Analysis of 
Senescence-Related Differentiation Potentials and Gene Expression Profiles in Human Dental 
Pulp Stem Cells. Cells Tissues Organs 203, 1–11. https://doi.org/10.1159/000448026 
Young, F., Sloan, A., Song, B., 2013. Dental pulp stem cells and their potential roles in central nervous 
system regeneration and repair: Dental Pulp Stem Cells in CNS Repair. J. Neurosci. Res. 91, 
1383–1393. https://doi.org/10.1002/jnr.23250 
Young, F.I., Telezhkin, V., Youde, S.J., Langley, M.S., Stack, M., Kemp, P.J., Waddington, R.J., Sloan, 
A.J., Song, B., 2016. Clonal Heterogeneity in the Neuronal and Glial Differentiation of Dental 
Pulp Stem/Progenitor Cells. Stem Cells Int. 2016, 1–10. https://doi.org/10.1155/2016/1290561 
Yu, C.Y., Boyd, N.M., Cringle, S.J., Alder, V.A., Yu, D.Y., 2002. Oxygen distribution and consumption 
in rat lower incisor pulp. Arch. Oral Biol. 47, 529–536. https://doi.org/10.1016/S0003-
9969(02)00036-5 
Yu, J., Wang, Y., Deng, Z., Tang, L., Li, Y., Shi, J., Jin, Y., 2007. Odontogenic capability: bone marrow 
stromal stem cells versus dental pulp stem cells. Biol. Cell 99, 465–474. 
https://doi.org/10.1042/BC20070013 
Zengin, E., Chalajour, F., Gehling, U.M., Ito, W.D., Treede, H., Lauke, H., Weil, J., Reichenspurner, H., 
Kilic, N., Ergün, S., 2006. Vascular wall resident progenitor cells: a source for postnatal 
vasculogenesis. Development 133, 1543–1551. https://doi.org/10.1242/dev.02315 
Zhang, D., Zhang, S., Wang, J., Li, Q., Xue, H., Sheng, R., Xiong, Q., Qi, X., Wen, J., Fan, Y., Zhou, 
B.O., Yuan, Q., 2020. LepR-Expressing Stem Cells Are Essential for Alveolar Bone 
Regeneration. J. Dent. Res. 99, 1279–1286. https://doi.org/10.1177/0022034520932834 
Zhang, F., Basinski, M.B., Beals, J.M., Briggs, S.L., Churgay, L.M., Clawson, D.K., DiMarchi, R.D., 
Furman, T.C., Hale, J.E., Hsiung, H.M., Schoner, B.E., Smith, D.P., Zhang, X.Y., Wery, J.-P., 
Schevitz, R.W., 1997. Crystal structure of the obese protein Ieptin-E100. Nature 387, 206–209. 
https://doi.org/10.1038/387206a0 
Zhang, W., Frank Walboomers, X., van Kuppevelt, T.H., Daamen, W.F., Bian, Z., Jansen, J.A., 2006. 
The performance of human dental pulp stem cells on different three-dimensional scaffold 
materials. Biomaterials 27, 5658–5668. https://doi.org/10.1016/j.biomaterials.2006.07.013 
Zhao, H., Chai, Y., 2015. Stem Cells in Teeth and Craniofacial Bones. J. Dent. Res. 94, 1495–1501. 
https://doi.org/10.1177/0022034515603972 
Zhou, T., Pan, J., Wu, P., Huang, R., Du, W., Zhou, Y., Wan, M., Fan, Y., Xu, X., Zhou, Xuedong, 
Zheng, L., Zhou, Xin, 2019. Dental Follicle Cells: Roles in Development and Beyond. Stem 
Cells Int. 2019, 1–17. https://doi.org/10.1155/2019/9159605 
Zhu, C., Yu, J., Pan, Q., Yang, J., Hao, G., Wang, Y., Li, L., Cao, H., 2016. Hypoxia-inducible factor-2 
alpha promotes the proliferation of human placenta-derived mesenchymal stem cells through 
the MAPK/ERK signaling pathway. Sci. Rep. 6, 35489. https://doi.org/10.1038/srep35489 
Zimmermann, K.W., 1923. Der feinere Bau der Blutcapillaren. Z. Für Anat. Entwicklungsgeschichte 68, 
29–109. https://doi.org/10.1007/BF02593544 
Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., 
Benhaim, P., Hedrick, M.H., 2002. Human Adipose Tissue Is a Source of Multipotent Stem 































Publication in Preparation  
Ethical Approval 
Patient Information Leaflet 
Consent Form 





















Besi, E., Vezzani, B., Fracaro L., Gomez-Salazar, M., Crisan, M., Péault, B. 















































1 of 2 
 







Participant Information Sheet (Stem cell version 1.2) 
Lothian NRS BioResource 




You are being invited to donate tissue samples to the Lothian NRS  BioResource.    
Before you decide whether or not to do this, it is important for you to understand what 
the BioResource is and what will be involved.  Please take time to read the following 
information carefully. Talk to others about the study if you wish.  Contact us if there is 
anything that is not clear or if you would like more information.  Take plenty of time to 
decide whether or not you wish to take part. 
 
 
What is the purpose of the study? 
The Lothian NRS BioResource is funded by the CSO (Chief Scientist Office) which is part of the 
Scottish Government Health Directorates. This is a collaboration which has been set up 
between Scottish Universities and Health Boards. Its aim is to help translate discoveries made 
in research laboratories into improved care for patients. 
The Lothian NRS BioResource will collect and store biospecimens (small pieces of tissue, 
cells and samples of body fluids) and build up a collection of these for use in medical research 
and education.  This BioResource is being run by NHS Lothian, and has been approved by a 
Research Ethics Committee.  The samples will only ever be used in research applications which 
have been approved by a scientific review committee. 
 
What is tissue and why is it required for research and education?  
The human body is made up of cells which are the basic building blocks for tissues.  Organs 
such as lungs, liver, kidney and appendix are made up of tissue. There are many different types 
of cells and tissues in the human body. Body fluids such as blood, urine and saliva contain cells. 
Material taken during a cervical smear test also contains cells. Doctors and scientists need 
human tissue and other biospecimens for medical research.  From these they can see and 
understand how diseases start and develop. They can also try out different drugs and tests on 
the tissue. This may help them find new medicines and treatments, and possibly even ways of 
diagnosing diseases earlier. They may grow adult stem cells from your tissue to help develop 
ways of repairing injured or diseased cells.  
As well as providing care and treatment for patients, the NHS is also responsible for educating 
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in research laboratories into improved care for patients. 
The Lothian NRS BioResource will collect and store biospecimens (small pieces of tissue, 
cells and samples of body fluids) and build up a collection of these for use in medical research 
and education.  This BioResource is being run by NHS Lothian, and has been approved by a 
Research Ethics Committee.  The samples will only ever be used in research applications which 
have been approved by a scientific review committee. 
 
What is tissue and why is it required for research and education?  
The human body is made up of cells which are the basic building blocks for tissues.  Organs 
such as lungs, liver, kidney and appendix are made up of tissue. There are many different types 
of cells and tissues in the human body. Body fluids such as blood, urine and saliva contain cells. 
Material taken during a cervical smear test also contains cells. Doctors and scientists need 
human tissue and other biospecimens for medical research.  From these they can see and 
understand how diseases start and develop. They can also try out different drugs and tests on 
the tissue. This may help them find new medicines and treatments, and possibly even ways of 
diagnosing diseases earlier. They may grow adult stem cells from your tissue to help develop 
ways of repairing injured or diseased cells.  
As well as providing care and treatment for patients, the NHS is also responsible for educating 
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Participant Information Sheet (Stem cell version 1.2) 
Lothian NRS BioResource 




You are being invited to donate tissue samples to the Lothian NRS  BioResource.    
Before you decide whether or not to do this, it is important for you to understand what 
the BioResource is and what will be involved.  Please take time to read the following 
information carefully. Talk to others about the study if you wish.  Contact us if there is 
anything that is not clear or if you would like more information.  Take plenty of time to 
decide whether or not you wish to take part. 
 
 
What is the purpose of the study? 
The Lothian NRS BioResource is funded by the CSO (Chief Scientist Office) which is part of the 
Scottish Government Health Directorates. This is a collaboration which has been set up 
between Scottish Universities and Health Boards. Its aim is to help translate discoveries made 
in research laboratories into improved care for patients. 
The Lothian NRS BioResource will collect and store biospecimens (small pieces of tissue, 
cells and samples of body fluids) and build up a collection of these for use in medical research 
and education.  This BioResource is being run by NHS Lothian, and has been approved by a 
Research Ethics Committee.  The samples will only ever be used in research applications which 
have been approved by a scientific review committee. 
 
What is tissue and why is it required for research and education?  
The human body is made up of cells which are the basic building blocks for tissues.  Organs 
such as lungs, liver, kidney and appendix are made up of tissue. There are many different types 
of cells and tissues in the human body. Body fluids such as blood, urine and saliva contain cells. 
Material taken during a cervical smear test also contains cells. Doctors and scientists need 
human tissue and other biospecimens for medical research.  From these they can see and 
understand how diseases start and develop. They can also try out different drugs and tests on 
the tissue. This may help them find new medicines and treatments, and possibly even ways of 
diagnosing diseases earlier. They may grow adult stem cells from your tissue to help develop 
ways of repairing injured or diseased cells.  
As well as providing care and treatment for patients, the NHS is also responsible for educating 
and training doctors, nurses and other healthcare workers.  Human tissue is needed for this as 
well. 
 
 
 
 
 
